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Abstract 
Introduction: Postprandial lipidemia (PPL), defined as an increase in plasma levels of 
triglyceride-rich lipoproteins following the consumption of a high fat meal (HFM) is 
associated with endothelial dysfunction.  Acute exercise reduces PPL and maintains 
endothelial function (EF) in healthy adults.  The effect of acute exercise on PPL and 
endothelial function has not been studied in patients with peripheral arterial disease (PAD).  
Purpose: To examine the effect of an acute bout of exercise on PPL, vascular inflammation 
and endothelial function in men with PAD. 
Methods:  Men (n=8) with PAD underwent two oral fat tolerance tests (OFTT).  On the 
evening prior to each OFTT, participants rested (control), or exercised until they expended 
200 Kcal.  Blood samples were obtained at baseline and 30 min, 1, 2, 3 and 4 h postprandial.  
Endothelial-dependent dilation (EDD) and endothelial-independent dilation (EID) were 
measured in the brachial artery using ultrasonography at baseline, 2 h and 4 h postprandial.  
Results: Postprandial TG increased significantly and EDD decreased significantly following 
the OFTT.  An acute bout of discontinuous exercise that resulted in a 200 Kcal expenditure 
did not significantly attenuate the post prandial TG response or significantly ameliorate the 
decrease in endothelial vasomotor function.  Compared to baseline values, circulating 
leukocytes, and TNF-α increased (p<0.05) in both conditions 4 h postprandial.  There were 
no changes in C-Reactive Protein  (CRP). 
Conclusion: Prior exercise has no effect on PPL or EDD following an OFTT in men with PAD. 
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Chapter 1  
INTRODUCTION 
 Peripheral arterial disease (PAD) is a distinct atherothrombotic syndrome 
marked by stenosis of peripheral arteries, typically those in the lower extremities, causing 
inadequate blood flow to the limbs.  Intermittent claudication (IC) is the most common 
symptom of PAD and is characterized by the onset of pain in the lower extremities during 
exercise that is relieved with rest (6).  
Supervised aerobic exercise has been shown to increase maximum walking 
distance in patients with PAD [1].  However, recent studies indicate that acute bouts of 
exercise to the onset of intermittent claudication may cause a systemic thrombo-
inflammatory response in this population [2,3].  This may be due to the fact that exercising 
to the onset of intermittent claudication, followed by reperfusion on rest, results in the 
formation of oxygen-derived free radicals (ODFR) and cytokines (3-5).  Oxygen-derived free 
radicals cause lipid peroxidation, which results in structural damage to the vascular 
endothelium and increased vascular permeability. 
 The endothelium is a 0.2- to 4-µm-thick monolayer of squamous endothelial 
cells that line the lumen of the entire surface of the vascular tree and plays an important 
role in the regulation of vascular tone, haemostasis, immune and inflammatory responses 
(1).  Damage to the endothelium from mechanical forces and processes related to 
cardiovascular disease risk factors and the resulting inflammatory response can generate a 
pro-thrombotic environment favourable for the initiation and progression of atherosclerosis 
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(1-4), the most frequent underlying cause of PAD.  The risk factors for PAD include age, male 
gender, family history, diabetes, smoking, hypertension and hyperlipidaemia (5, 6).   
Postprandial lipemia (PPL) describes the increase in plasma levels of triglyceride-rich 
lipoproteins for up to 8 h following the consumption of a high fat meal (HFM), and may 
represent an independent risk factor for atherosclerotic cardiovascular disease (ACVD)(7).  
In contemporary Western societies the vasculature is commonly exposed to prolonged 
postprandial hyperlipidemia.  It has been estimated that individuals consuming a typical 
Western diet spend approximately 18 h per day in a postprandial state (8).  The adverse 
effect of postprandial triglycerides (TG) is thought to be mediated by proatherogenic 
lipolysis products of nascent triglyceride-rich lipoproteins, such as remnant like particles 
(RLP) and fatty acids.  Even a transient increase in these proatherogenic products may 
increase pro-coagulant and pro-inflammatory activity (7) and impair endothelial dependent 
vasodilatation (EDD) (9), a predictor of atherosclerosis and future cardiovascular events.   
Physical activity and physical fitness are associated with a lower incidence of CVD.  
The relative risk of death from CVD in the most active individuals is half that of their 
sedentary counterparts (10).  The cardioprotective effect of exercise may be mediated in 
part by an influence on TG metabolism.  Acute exercise 1-16 h prior to feeding a standard 
HFM can significantly reduce the postprandial TG response in adults (11, 12).   
The available evidence suggests that total energy expenditure (TEE) may be more 
critical than exercise intensity in influencing postprandial TG metabolism.  In addition, the 
exercise benefits can be accumulated over the course of a day in two or three shorter bouts.  
The possibility of accumulating benefit with multiple short bouts is particularly important for 
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patients with PAD as in many instances the disease restricts their ability to exercise for 
prolonged periods.  To date, no studies have evaluated the effect of exercise on 
postprandial lipemia in patients with PAD.  The purpose of this study is to examine the 
effects of an acute bout of exercise on postprandial lipemia and endothelial function in men 
with PAD. 
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Specific Aims 
1. To compare the effects of a standardised OFTT with and without a prior acute 
exercise bout on postprandial TG in men with PAD 
2. To compare the effects of a standardised OFTT meal with and without a prior 
acute exercise bout on circulating markers of inflammation in men with PAD 
3. To compare the effects of a standardised OFTT with and without a prior acute 
exercise bout on brachial artery flow mediated dilation in men with PAD 
Study Hypothesis 
1. In men with PAD, the postprandial TG response to a standardised OFTT will be 
significantly lower when the meal is preceded with an acute exercise bout 
compared to no exercise 
2. In men with PAD, the circulating levels of inflammatory markers in response to a 
standardised OFTT will be significantly lower when the meal is preceded with an 
acute exercise bout compared to no exercise 
3. In men with PAD, brachial artery flow mediated dilation following a standardised 
OFTT will be significantly greater when the meal is preceded with an acute 
exercise bout compared to no exercise 
  
5 
 
Chapter 2  
LITERATURE REVIEW 
Peripheral Arterial Disease 
Peripheral arterial disease (PAD) has been defined as obstruction of blood flow into 
an arterial tree excluding the intracranial or coronary circulations (Figure 2.1) (13). 
 
 
 
 
 
 
 
Figure 2.1:  Development of atherosclerotic lower extremity PAD 
It represents a continuum of disorders that range from asymptomatic PAD, 
symptomatic IC, and critical limb ischemia (CLI) (Figure 2.2).  Patients with PAD develop 
atherosclerotic occlusive lesions in the arteries supplying the lower extremities, and 
limitation in blood flow to active muscles is the primary pathophysiologic event.  A number 
of arterial segments can be affected, including the inflow vessels (aorta and iliac arteries), 
and also the femoral, popliteal, and tibial vessels in the leg (14).   
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Figure 2.2: Natural history of atherosclerotic lower extremity PAD 
The figure presents 1-year outcomes for patients who present with critical limb ischemia. As 
illustrated, all patients with lower extremity PAD are at risk of progressive limb ischemia and are at 
high risk of fatal and nonfatal atherothrombotic events, including myocardial infarction and stroke 
PAD prevalence is 3-12% in the general population, with IC prevalence of 1-2% (15; 
16).  PAD prevalence increases significantly with age, affecting up to 20% of patients >75 
years (17, 18).  Coexistent coronary artery disease (CAD) and cerebrovascular disease 
(CBVD) are common in patients with PAD, particularly in the elderly population.  The 
coexistence of CAD and stroke was found to be 68% and 42% respectively, among men > 50 
years of age in an academic, hospital-based geriatric practice (19).  The prevalence of PAD 
may be vastly underestimated due to the fact that the majority of individuals with lower 
extremity PAD do not experience recognisable ischemic symptoms in the limb, and are 
therefore classed as being 'asymptomatic' (5). 
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Diagnosis of PAD 
The ankle brachial index (ABI) is a simple, reproducible, and cost-effective non-
invasive assessment that is commonly used to detect lower-extremity arterial stenosis (5).  
It is determined by measuring systolic blood pressure in the posterior tibial and/or the 
dorsalis pedis arteries in both legs, with the lowest ankle pressure then divided by the 
brachial systolic blood pressure (Figure 2.3).  When used by trained technicians, ABI is a 
reliable and valid assessment tool for detecting stenosis ≥ 50% in leg arteries (20).   
 
 
 
 
 
 
 
Figure x 
Normal ABI ranges from 0.91 to 1.30.  Decreases in ABI are consistent with PAD, and 
an ABI cut-off of  0.9 is used as the indicator of PAD (22) (Table 2 1).  Mild to moderate PAD 
usually produces an ABI in the range of 0.41 to 0.90.  A reading below 0.40 indicates the 
presence of severe PAD.  Resnick et al (22) examined all-cause and CVD mortality in relation 
to low and high ABI in 4393 American Indians in the Strong Heart Study.  They showed a U-
ABI is defined as: 
Highest ankle systolic pressures (posterior 
tibial or dorsalis pedis) mmHg 
Highest brachial artery systolic pressure mmHg 
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shaped association between ABI and mortality, with significantly increased risk in both the 
<0.90 and >1.40 groups. 
ABI Interpretation 
>1.30 Normal, but considered incompressible (calcified) arteries 
0.91–1.30 Normal range 
0.41–0.90 Mild to moderate PAD 
0.5–0.74 Consistent with moderate peripheral arterial disease (intermittent 
claudication or rest pain) 
< 0.4 Severe PAD 
Table 2.1: Interpretation of ankle-brachial index (ABI) values 
Invasive methods such as duplex scanning, magnetic resonance imaging (MRI), and 
digital subtraction angiography are commonly used for anatomical localisation of arterial 
disease prior to intervention rather than for initial diagnosis. 
Intermittent Claudication 
Intermittent claudication (IC), defined as exercise-induced muscle pain that is 
relieved with rest, is one the most common symptoms in patients with lower extremity PAD 
(4).  Symptoms may be described as pain, achiness, a sense of fatigue, or nonspecific 
discomfort that occurs with exercise.  Symptoms normally dissipate following several 
minutes of rest (23).   
The location of the pain is an indication of the site of arterial occlusion (Figure 2.4) 
(24).  Claudication of the calf is usually the result of an occlusion in the superficial femoral 
artery.  The most frequently affected artery in intermittent claudication is the popliteal 
artery; symptoms are most common in the calf muscles (25).  This artery is an extension of 
the femoral artery and continues below the knee where it branches off and carries blood to 
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the muscles in the calf and foot.  Hip, thigh, and buttock claudication are associated with 
occlusion of the aorta and iliac arteries (25).  
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4:  Location of the pain associated with PAD 
Critical Limb Ischemia 
CLI is defined as PAD causing lower-extremity pain at rest or imminent limb loss 
caused by severe impairment of blood flow to the affected limb, and is classified as Fontaine 
Class III (26).  The Fontaine Classification is the method by which chronic peripheral 
ischaemia is classified.  CLI is a manifestation of PAD that describes patients with chronic 
ischemic rest pain, foot and leg ulcers, or gangrene.  Discomfort is often worse in a supine 
position and pain can be reduced when the limb is placed in a dependant position.  CLI 
results from the presence of multilevel occluded vessels that impair blood flow and distal 
perfusion pressure to a level insufficient to satisfy the nutritive needs of the limb at rest 
(13).  Approximately 500–1000 people per million of the population are diagnosed with CLI 
(27). PAD patients with diabetes are at a greater risk of CLI, and risk of amputation is 
increased 5 fold in this population (28).  
The clinical diagnosis of CLI should be confirmed by haemodynamic parameters such 
as the ankle or toe systolic pressure.  Ischemic rest pain most commonly occurs below an 
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ankle pressure of 50 mmHg or a toe pressure <30 mmHg.  Up to 30% of patients with lower 
extremity PAD will progress from IC to CLI over the course of their disease (27, 29).  
Approximately 25% of patients die and a further 30% require a major amputation one year 
after CLI diagnosis (27).  Owing to the high risk of limb loss and fatal and nonfatal vascular 
events, it is vitally important to diagnose CLI quickly.  The severity of the symptoms of PAD 
can be classified according to either the Fontaine or Rutherford scales (Table 2.2).  
 
Table 2.2: Classification of peripheral artery disease (Fontaine and Rutherford scale adapted 
from Norgren et al, 2007) 
Fontaine  Rutherford 
Stage  Clinical   Grade Category Clinical  
I Asymptomatic   0 0 Asymptomatic  
IIa Mild claudication   I 1 Mild claudication  
IIb Moderate to severe claudication   I 2 Moderate claudication  
III Ischemic rest pain   I 3 Severe claudication  
IV Ulceration or gangrene  II 4 Ischemic rest pain  
  
 III 5 Minor tissue loss  
  
 III 6 Major tissue loss 
Risk Factors in PAD 
The primary etiology of PAD is atherosclerosis, and the risk factors are similar to 
those for coronary artery and cerebrovascular disease.  Age, smoking and diabetes are the 
most powerful risk factors for PAD.  Others include African American ethnicity, dyslipidemia, 
hypertension, hyperhomocysteinemia, elevated C-reactive protein (CRP) levels, and chronic 
renal insufficiency (30). 
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The prevalence of PAD increases with age.  A strong association between advanced 
age (≥ 70years) and PAD prevalence has been shown in the National Health and Nutrition 
Examination Survey (NHANES) 1999–2000.  The prevalence of PAD was 4.3% in subjects 
aged 40 years or older compared with 14.5% in those aged 70 years or older (30).  In 1985, 
Criqui et al., reported the prevalence of PAD to be 2% to 3% in individuals aged 50 years or 
less compared with 20% in those aged greater than 75 years (33). 
Diabetes and smoking are the two most common modifiable risk factors for PAD.  
Results from a survey conducted in Sweden found that 21% of diabetic patients had signs of 
PAD (34).  In a cross-sectional analysis of a 4153 Greek adults (37), the odds ratio for 
vascular disease was 1.94 for patients with the metabolic syndrome, 3.04 for patients with 
the metabolic syndrome and diabetes, and 1.48 for patients with the metabolic syndrome 
but no diabetes.  The association of smoking and PAD is dose-dependent; the risk of PAD 
increases with years smoked and packs smoked per year. (38). The incidence of PAD 
increases from 2.6% in never smokers to 4.5% in moderate smokers (0-25 pack/year) to 
9.8% in heavy smokers (>25 pack/year) (39).  More than 80% of individuals with PAD are 
current or former smokers (35, 40). Individuals of African American ethnicity are 
approximately 3-4 times more likely to develop PAD compared to their non-African white 
counterparts (31, 32). 
The common dyslipidemia found in PAD is similar to insulin resistance, enforcing the 
strong association between diabetes with PAD (41).  Patients with PAD have higher 
circulating levels of triglycerides (42), lower levels of high-density lipoprotein cholesterol 
(HDL-C) and higher levels of total cholesterol than healthy individual’s subjects (42).  The risk 
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of PAD increases by 5-10% for each 10mg/dL increase in total cholesterol (43).  In a cross 
sectional study involving 708 men, aged 55-74., Planas et al., (44) found that the waist-to-
hip ratio was independently associated with PAD.  CRP, an acute-phase reactant produced 
by the liver in response to inflammation, is one of many circulating inflammatory markers 
that is related to CAD and may play a role in its pathogenesis.  There is evidence of a linear 
relation between CRP concentrations and the severity of PAD (34). 
Treatment of PAD 
The goals of treatment for individuals with PAD are to prevent progression of PAD, 
prevent coronary or cerebrovascular events, and for those with IC to relive symptoms, 
improve functional capacity and improve quality of life (34).  For all patients across the PAD 
spectrum risk factor modification is recommended, including weight loss, smoking 
cessation, lipid-lowering therapy, anti-platelet therapy and increased exercise (23).  
Recommendations for individuals with IC include supervised exercise interventions and 
pharmacological therapies (Cilostazol and pentoxifyline).  Cilostazol reduces the pain of 
intermittent claudication by dilating the arteries, thereby improving the flow of blood and 
oxygen to the legs.  Pentoxifylline improves blood flow by making it easier for red blood cells 
to pass through vessels. It also decreases the viscosity of blood.  Surgical or endovascular 
intervention is usually reserved for patients with severe, lifestyle-limiting symptoms that do 
not adequately respond to conservative management, including pharmacologic treatment.  
Treatment of PAD – Exercise  
The physiological, metabolic, and mechanical alterations that occur during periods of 
exercise presumably stimulate an adaptive response that ultimately reduces claudication 
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symptoms and improves functional capacity.  Exercise training improves maximal walking 
ability by an average of 150% (45-51).  Improvements in walking ability are most often 
attained when exercise sessions >30 min are undertaken at least 3 times per week for 6 
months and involve walking to near maximal pain (52, 53).  The exact mechanisms by which 
exercise training yields improvements in walking ability remain unclear. 
The increased blood flow in response to repeated periods of exercise-induced 
hyperemia may alter vascular structure and function (54).  Angiogenesis in response to 
exercise training may increase blood flow to skeletal muscle, distal to the stenosis (55).  
However, studies examining the effect of exercise training on leg blood flow have been 
equivocal. Gardner et al., 2001 found that 6 months of exercise training increased reactive 
hyperaemic blood flow by 27% and max calf blood flow by 30% in patients with PAD.  The 
improvements in blood flow were associated with improved walking ability.  However, 
resting blood flow and ABI were not altered in response to training (56).  In contrast, a 
number of studies have reported no changes in leg blood flow in patients with improved 
walking ability after an exercise program (57, 58), suggesting that other mechanisms may be 
responsible for the large improvements observed following exercise training. 
Impaired endothelial dependent vasodilation (EDD) has been demonstrated in 
patients with PAD (59) and in patients with risk factors for atherosclerosis, such as type 2 
diabetes, (60) hypertension, and hyperlipidemia (61).  Results from studies in patients with 
other chronic diseases, suggest that exercise training improves endothelial-dependent 
vasodilatation (62, 63).  Brachial artery flow mediated dilation (FMD) was found to be 
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significantly decreased in men with PAD, 30 min and 2 h following 10 min of treadmill 
exercise to intolerable ischaemic pain in the affected lower extremity exercise (64).   
Exercise training may improve abnormal hemorheology in patients with claudication, 
thereby facilitating oxygen delivery (65).  Hemorheology refers to the properties of flowing 
blood and its elements specifically, plasma viscosity, hematocrit, red cell deformability, and 
red cell aggregation.  Ernst & Matrai 1987 et al., found that treadmill walking at 3 km/hr to 
absolute claudication twice a day, five days per week for 2 months resulted in significant 
normalization of blood and plasma viscosity, blood cell filterability, and red cell aggregation.  
No changes occurred in a non-exercise control group (66).   
Chronic ischemia of PAD results in metabolic abnormalities in the affected skeletal 
muscle.  PAD is associated with increased plasma and skeletal muscle short-chain 
acylcarnitine content (23).  Resting muscle short-chain acylcarnitine content is inversely 
correlated with claudication limited functional capacity (23).  The degree of metabolic 
dysfunction is a better predictor of functional capacity than haemodynamic measurements.  
In patients with unilateral claudication, the increase in acylcarnitines only occurred in the 
affected skeletal muscle, indicating that this metabolic abnormality was specific to the limb 
with reduced blood flow (67).  Patients with the greatest accumulation of acylcarnitines had 
the lowest treadmill exercise performance.  Treadmill exercise training, but not resistance 
training, reduces plasma levels of acylcarnitine accumulation (68).  Improvements in 
maximal walking ability may also be related to changes in walking efficiency or improvement 
in the tolerance of claudication pain (23).  
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Treatment of PAD - Pharmacotherapy 
Effective drug therapies include aspirin, pentoxifylline and cilostazol (71).  
Pentoxifylline is a methylxanthine derivative with hemorrheologic and immunomodulating 
properties.  It reduces blood viscosity, changes the morphology of red blood cells, and 
decreases the potential for platelet aggregation and thrombus formation.  Cilostazol is a 
quinolinone derivative that inhibits cellular phosphodiesterase III.  It suppresses platelet 
aggregation, activates lipoprotein lipase, and causes arterial dilation (69).  A large randomly 
controlled prospective trial found that cilostazol was significantly better than pentoxifylline 
or placebo for increasing walking distances in patients with moderate to severe PAD (70).  
The improvement in treadmill walking performance with pentoxifylline was not significantly 
different from the placebo (70).  Data supporting use of pentoxifylline for claudication is 
weak, and pentoxifylline is not generally accepted as efficacious.   
Aspirin and clopidogrel are often used as antithrombotic therapies in PAD.  They 
have not been shown to improve symptoms of intermittent claudication but are important 
in reducing cardiovascular complications associated with the presence of atherosclerosis 
and PAD.  The Antithrombotic Trialist Collaboration (ATT) found that even a low dose of 
aspirin (75–150mg) reduced vascular events by 32% in patients with PAD (71).  However, the 
Clopidogrel versus Aspirin in Patients at Risk of Ischaemic Events (CAPRIE) trial found that 
clopidogrel treatment in patients with symptomatic PAD was more effective than aspirin in 
preventing ischemic events, 5.83% and 5.32% for clopidogrel and aspirin, respectively (72). 
Treatment for CLI can be quite complex, but the primary aim should be to reduce the 
pain and improve blood flow in order to minimize the need for amputation.  The majority of 
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patients with CLI will ultimately require a revascularization procedure.  Endovascular 
therapy is now the primary strategy for management of CLI.  Patients with CLI not eligible 
for arterial reconstruction, prostanoids are the only vasoactive drugs with proven efficacy. 
Creutzig et al., (73) concluded in a recent meta-analysis of randomized placebo-controlled 
trials, of patients with stage III or IV PAD that PGE1 therapy not only had significant 
beneficial effects over placebo on ulcer healing and pain relief, but also increased the 
number of patients surviving with both legs at 6-months follow-up. 
Atherosclerosis and Endothelium 
Atherosclerosis is the most frequent underlying cause of PAD (6).  It is characterized 
by the accumulation of monocyte-derived macrophages within the vessel wall and the 
accompanying inflammatory response.  This process is initiated by the transmigration and 
retention of low density lipoprotein cholesterol (LDL-C) in the sub-endothelial extracellular 
matrix, where it is subjected to chemical modification, and converted to oxidized LDL 
(OxLDL), a key pathogenic mediator of atherosclerosis (Figure 4.5) (107).   
OxLDL stimulates inflammatory signaling by endothelial cells, resulting in the 
expression of membrane-bound adhesion molecules that facilitate the attachment of 
circulating leukocytes to the vessel wall, and induce smooth muscle cell proliferation.  
Attachment of monocytes facilitates their migration across the endothelium into the 
subendothelial space where they differentiate into macrophages.  Macrophages engulf 
OxLDL, leading to the formation of large foam cells, a major component of early lesions.  
Systemic inflammatory markers of vascular inflammation include an elevated white blood 
cell count (WBC), and high circulating levels of CRP and TNF-α.   
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Figure 4.5:  Summary of the atherosclerotic disease progression and developmnet 
Endothelium and Endothelial Function 
Endothelial cells form a continuous monolayer that line blood vessels of the entire 
vascular tree, and represent a surface area of approximately 4000 to 7000 m2.  Malpighi's 
discovery in the 17th century of the endothelium as a physical separation between blood 
and tissue with no substantial functionality persisted throughout the nineteenth and 
twentieth centuries (74).  Landmark studies in the 1980’s demonstrated the obligatory role 
of endothelial cells in acetylcholine (ACh)-mediated vasodilation (75) and in the paradoxical 
ACh-mediated vasoconstriction of atherosclerotic vessels (76).  The endothelium is now 
viewed as a complex dynamic barrier that plays a crucial role in maintaining vascular 
integrity.   
The endothelium-dependent vasodilatory response to exogenously administered 
acetylcholine (ACh) is attributable to the production and diffusion of nitric oxide (NO), a 
hydrophobic diatomic gas produced in response to changes in shear forces, or via a variety 
of agonists acting on specific endothelial cell membrane receptors (Figure 4.6) (81).  In 
addition to its vasodilatory effects, NO counteracts leukocyte adhesion to the endothelium, 
attenuates vascular smooth muscle proliferation and migration, influences the production 
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of superoxide anion, suppresses platelet aggregation and protects against vascular injury, 
inflammation, and thrombosis, key events in the development and progression of 
atherosclerosis  (77). 
 
 
 
Figure 4.6:  Molecular structure of nitric oxide 
Cardiovascular disease risk factors such as aging and a family history of CVD, active 
and passive smoking, lipid disorders, hypertension, diabetes mellitus, obesity, and physical 
inactivity, among others, have been shown to promote the development of atherosclerosis 
through their deleterious effects on endothelial structure and function (78).  Damage to the 
endothelium caused by cardiovascular disease risk factors results in the reduction of nitric 
oxide (NO) bioavailability.  The progressive inability of endothelial cells, exposed to risk 
factors, to generate sufficient NO promotes a vascular phenotype prone to atherogenesis 
(79). 
The functional and structural integrity of the endothelium is critical in maintaining 
vascular homoeostasis, and the presence of atherosclerosis has been shown to affect the 
vasomotor responses of the diseased vessel to shear stress, and a number of vasoactive 
compounds (80).  Flow-mediated dilation (FMD) is a commonly used non-invasive procedure 
to assess endothelial function.  It is based on the assumption that healthy, intact endothelial 
cells can detect, and dilate, to changes in shear stress following a brief period of occlusion 
(62).  The percentage change in arterial diameter in response to shear stress can be 
measured using high-resolution B mode ultrasonography, and is believed to be endothelial-
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dependent and mediated by NO.  Diameter changes are also measured after administration 
of glyceryl-trinitrate to assess the response of the vessel to endothelium-independent 
vasodilation (81). 
The prognostic significance of endothelial function as a predictor of cardiovascular 
events in healthy individuals and in patients with CAD and those with normal coronary 
arteries and risk factors for atherosclerosis has been addressed in a number of studies (82, 
83, 84,).  Interventions proven to reduce cardiovascular risk, such as weight loss, smoking 
cessation, lipid-lowering therapy, and angiotensin-converting enzyme (ACE) inhibitors been 
shown to improve endothelial function and decrease cardiovascular risk (85). 
Endothelial Function – Exercise 
Evidence from both cross-sectional and longitudinal studies indicate that 
cardiorespiratory fitness delays the decrease in endothelial function associated with ageing 
(86) and reverses impaired endothelial function in individuals with atherosclerotic CVD (87).  
Exercise-induced improvements in vascular function appear to occur more readily and with 
remarkable consistency in vessels with antecedent functional impairment.  Improvements in 
endothelial function induced by exercise training are attributable to a combination of 
enhanced vasodilatory capacity and arterial remodelling (62).  
Observations that a single bout of exercise can transiently alter atherosclerotic CVD 
risk factors (89) have led to the notion that perhaps some of the effects of exercise on 
endothelial function may be attributable to the acute effect of exercise.  A number of 
studies have investigated the effect of an acute bout of exercise on endothelial function in 
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healthy and disease populations.  Table 2.4 provides a summary overview of studies that 
have examined the effect of acute exercise on endothelial function. 
Cycling for 30 min at 50% VO2peak increases brachial artery FMD in young female 
smokers (90), and treadmill exercise for 34 min at 60% VO2max almost doubled brachial 
artery FMD in premenopausal women (91) but had no effect on brachial artery FMD in 
postmenopausal women.  Both low volume high-intensity interval exercise and moderate-
intensity endurance exercise significantly increased absolute FMD and normalized brachial 
artery FMD 1 h post exercise in men and women with CAD (92).  Brachial artery FMD is 
enhanced 1 h following 45 min acute bouts of low-, moderate- and high-intensity treadmill 
exercise in active overweight men, but is attenuated in inactive overweight men (93). 
In contrast a number of studies have found a transitory functional deterioration in 
FMD in healthy individuals 1 h after a single bout of high-intensity interval running (94), non-
elite runners 1 h after completing a marathon, and healthy male smokers compared to non-
smokers (7.7 v 4.1%) immediately following 40 min of submaximal steady-state exercise on 
a cycle ergometer (95). 
Brachial artery FMD was found to be significantly decreased in men with PAD, 30 
min and 2 h following 10 min of treadmill exercise to intolerable ischaemic pain in the 
affected lower extremity exercise (64).  In contrast, Silvestro et al., found that an acute bout 
of treadmill exercise to the onset of claudication has no effect on brachial artery FMD 
measured 5 min post exercise in men and women (62 ± 2 year) with PAD (96).  In contrast, 
FMD was significantly impaired following treadmill exercise to maximal claudication pain, 
demonstrating that exercise-induced ischemia further deteriorates FMD.  Intravenous 
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administration of vitamin C ameliorates the impaired FMD response following treadmill 
exercise to maximal claudication pain only.  Others have shown that antioxidant treatment 
can prevent acute impairment in endothelial function.  The benefits of vitamin C on 
endothelial function are believed to be due to superoxide scavenging, and/or inhibition of 
LDL-C that takes place during high-intensity exercise.  Vitamin C is also an important 
regulator of the intracellular redox (96).   
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Table 2.3: Studies that examined the effect of acute exercise on endothelial function 
Author Patient Cohort Mode of Exercise Duration Intensity FMD 
Cosio-Lima (2006) Renal Transplant TM Walking 30 min 70 -  85% HRmax  
Gaenzer (2001) Smoking Cycling 40 min 50% VO2peak  
Silvestro (2002) PAD TM Walking Max claudication 3 km.h-1 @ 3%  
Harvey (2005) Pre & post-menopausal TM Walking    
Rooks (2011) Smoking/non-smokers Cycling 59% VO2peak 30 min  
Jones (2008) Diurnal Variation Intermittent Cycling 3 x 10 min 70% VO2peak  
Jones (2010) Diurnal Variation Intermittent Cycling 3 x 10 min 70% VO2peak  
Rognmo (2005) CV Fitness HII Running 5 x 5 min 90% HRmax 
 high fit  
 low fit 
 
Harris (2008) 
 
Overweight (8 active) Intermittent Cycling 45 min 
25% VO2peak 
50% VO2peak 
75% VO2peak 
 
Llewellyn (2012) Healthy TM Running 30 min 60% VO2max  
Currie (2012) CAD Intermittent vs. Continuous 10 x 1min vs 30 min 80% vs. 55% POpeak  
Dawson (2008) Nonelite Runners Marathon 42.2 km n/a  
Joras PAD TM Walking Max claudication 3.2 km.h-1 @ 12%  
CAD, coronary artery disease; FMD, flow-mediated vasodilation; Tm, Treadmill; HII, High intensity interval; HRmax, Heart rate max; PAD, peripheral arterial 
disease; VO2, oxygen consumption; PO, power output.
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Supervised treadmill exercise has been shown to improve vascular function, in 
patients with PAD.  McDermott et al., randomly assigned 156 patients with PAD to 6 months 
of supervised treadmill exercise, lower extremity resistance training, or a sedentary control 
group.  Improvements in brachial artery FMD were significantly greater at 6 months in the 
treadmill group than the resistance training, or the control group.  Changes in brachial 
artery FMD in the resistance training group were not different from the control group.  
Improvements in the 6-min walk test and maximum treadmill walking time were 
significantly greater in the treadmill exercise group than the resistance training group (97). 
Intermittent treadmill walking at 2.0 mph to near-maximal claudication pain 3 days a week 
for 6 months has also been shown to significantly improve brachial artery FMD.  Time to 
onset of IC pain increased by 94%, and the time to maximal claudication pain increased 43% 
with exercise (98).  
Another acute study also showed reduced FMD response following acute exercise in 
patients with PAD (100).  The exercise protocol involved walking at 3 km/hr and a 3% grade 
with a 3% grade increase every 2 minutes up to a maximum of 15%.  Patients exercise was 
stopped when claudication pain became intolerable, and FMD was assessed 5 minutes later.  
In patients with peripheral arterial disease, calf pain during walking, followed by a period of 
rest to allow reperfusion of the ischemic limb, induces increased oxidative stress and a 
marked inflammatory response (42, 48, 100). By reducing nitric oxide availability both these 
events may be responsible for the acute systemic endothelial insult observed in the present 
acute studies. 
  
Effect of Acute Exercise on Postprandial Lipemia and Endothelial Dysfunction in Men with Peripheral 
Arterial Disease 
__________________________________________________________________________________ 
24 
 
Lipids 
Lipids are a heterogeneous group of hydrophobic organic molecules that have a 
number of important physiological functions including the formation of membranes, energy 
storage, cellular signalling, protection, insulation and the production of steroid hormones 
and bile acids.  They can be broadly classified as fatty acids, acylglycerols, phospholipids, 
eicosanoids, steroids and lipoproteins (128). 
Acylglycerols are composed of a glycerol molecule with one (monoacylglycerol), two 
(diacylglycerol) or three (triacylglycerol) fatty acids attached at the hydroxyl group.  
Triacylglycerols, also termed triglycerides (TG), are the most abundant lipid in the body.  
Triglyceride and cholesterol are solubilised by their incorporation into small lipid-protein 
complexes termed lipoproteins.  Lipoproteins are classified according to their density as 
chylomicrons, very low density lipoproteins (VLDLs), intermediate density lipoproteins 
(IDLs), low density lipoproteins (LDLs) or high density lipoproteins (HDLs).  They contain 
different concentrations of protein, triglyceride, cholesterol, cholesterol esters and 
phospholipids (129).  
Triglyceride is the principal form in which fat is present in the diet.  Following their 
hydrolysis by pancreatic lipase, TGs combine with proteins, free cholesterol and 
phospholipids in the intestinal mucosal cells to form nascent chylomicrons.  The TG rich 
nascent chylomicrons are secreted into the lymphatic system and enter the circulation at 
the thoracic duct (129). 
Circulating nascent chylomicrons acquire additional apoproteins, Apo E and Apo C-II, 
from high density lipoprotein cholesterol (HDL-C) and become mature chylomicrons (128) 
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that are approximately 90% triglyceride, 5% cholesterol, 4% phospholipid and 1% protein.  
During their passage through the circulation, chylomicrons bind to lipoprotein lipase (LPL) 
on the surface of capillary endothelial cells resulting in the hydrolysis of TG to fatty acids 
and glycerol in a reaction that requires the presence of Apo C-II (128).  Fatty acids can then 
be oxidised as fuel by muscle or other cells, or alternatively they can be re-esterified to 
triglycerides and stored in adipose tissue (128).  Following removal of triglyceride the 
chylomicron is termed a chylomicron remnant.  Remnants are removed from circulation by 
hepatic cell surface receptor proteins. 
In addition to dietary TG, the liver also plays a key role in the synthesis and transport 
of lipids.  Hepatic derived cholesterol and triglyceride along with Apo B-100, phospholipid 
and small amounts of Apo E and Apo C are packaged into nascent VLDL particles (128) that 
consists of approximately 50% triglyceride, 20% phospholipids, 20% cholesterol and 10% 
protein (130). Following their release into the circulation, nascent VLDL particles acquire 
Apo E and Apo C from circulating HDL.  As with chylomicrons, TG is hydrolysed to free fatty 
acids and glycerol by lipoprotein lipase (130).  Some of the VLDL remnants ar cleared from 
circulation by binding of Apo B-100 and Apo E to hepatic LDL receptors (128).  The remaining 
triglyceride-depleted VLDL remnants are termed intermediate density lipoprotein (IDL).  
Through the action of hepatic lipase (HL) IDL can be further metabolised to produce low 
density lipoprotein (LDL) (128). 
LDL is made up of approximately 50% cholesterol, 25% protein, 20% phospholipids 
and 5% triglycerides (130) and functions to deliver free cholesterol to peripheral tissues 
(131).  LDL particles are cleared from circulation primarily by hepatic LDL receptors. 
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Postprandial Lipemia 
PPL is characterized by an increase in plasma levels of TGRL for up to 8 h following 
the consumption of a HFM.  Studies in healthy populations and those with CVD and CVD risk 
factors and clinical populations have shown that the postprandial period has a significant 
deleterious effect on endothelial function, as evidenced in reduced brachial artery FMD, 
increases in circulating adhesion molecules, cytokines and endothelial microparticles (1, 
102, 103, 9). The maximum impairment in EDD occurs 4 h postprandial, coinciding with the 
peak TG concentration, and continues for up to 8 h (9, 95).  Consecutive HFM causes further 
dysfunction to the endothelium, and greater oxidative stress for each consecutive meal (11).   
The concept of atherosclerosis as a postprandial phenomenon was first proposed by 
Zilversmit (1979) (104), and is related to the increased production of reactive oxygen species 
(ROS) including superoxide anion O2-, (105, 106, 103) which in turn reduces NO 
bioavailabilty.  A reduction in NO bioavailability has been identified as a primary pathogenic 
factor responsible for endothelial dysfunction.  Nitric Oxide (NO) is produced by nitric oxide 
synthase (NOS) which catalyzes the conversion of L-arginine to NO and L-citrulline.  Shear 
stress produced by laminar blood flow stimulate eNOS phosphorylation and is responsible 
for basal endothelial NO tone.  A decrease in eNOS activity or oxidative inactivation of NO 
have been shown to reduce NO bioavailability (38) Peluffo G, Radi R. Biochemistry of protein 
tyrosine nitration in cardiovascular pathology. Cardiovasc Res 75: 291–302, 2007. 
The reaction of NO reacts with superoxide radicals (O2-) results in a decrease in its 
concentration and the formation of peroxynitrite (-OONO).  Cardiomyocytes and endothelial 
and smooth muscle cells are major sites of O2
- production in the cardiovascular system.  
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When O2
- levels increase, NO is consumed and peroxynitrite is formed, hampering the 
diffusion of NO.  The reaction of NO with O2
- results in a loss of its protective action and the 
formation of peroxynitrite, a potent pro-oxidant.  This may result in a shift in the anti-
atherogenic actions of NO to a pro-atherogenic oxidative phenotype.   
Prospective studies in healthy population groups indicate that the postprandial 
triglyceride (TG) level is a more reliable predictor of future CVD events than fasting TG 
levels.  Specific TGRL remnants such as VLDL, LDL and lipoprotein B–containing particles are 
related to initiation and progression of atherosclerosis (107).  Transmigration of LDL 
particles across the vascular endothelium and their subsequent oxidation is a primary event 
in the atherosclerotic process.  Postprandial LDL particles are more easily oxidised than 
fasting LDL.  Similarly, postprandial VLDL particles may also be more prone to oxidation than 
fasting VLDL (108).   
The lipolysis products of oxidised chylomicrons have been identified as potential 
components of postprandial lipoproteins that increase endothelial permeability and 
stimulate adhesion molecule expression (132; 133).  Chylomicrons obtained following meals 
rich in polyunsaturated fats were more easily oxidised in vitro, and consistently induced 
higher levels of adhesion molecule expression (132, 133). 
Postprandial Lipemia and PAD 
PAD is associated with several lipid abnormalities including increased levels of fasting 
TGs and low levels of HDL-C.  In PAD patients with a normal lipid profile, administration of 
an oral fat load alters the lipid profile to one considered atherogenic, and characterized by 
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an increased magnitude of postprandial lipemia (increased AUIC-TG) and a reduction of 
HDL-C (22).  
Postprandial Lipemia and Exercise 
Moderate-intensity exercise performed 18 to 20 h before a HFM meal attenuates the 
postprandial increase in plasma TG (23).  The mechanisms responsible for the exercise 
related attenuation of postprandial TG are not fully understood.  Exercise reduces the 
fasting TG pool size, but the incremental area (above baseline) under the TG-time curve is 
also reduced compared with control conditions.  The exercise-induced plasma TG lowering 
effect may be due to increased activity of lipoprotein lipase, which could enhance the 
removal of TG-rich lipoproteins from the blood.  LPL activity is up-regulated after exercise in 
a time-course consistent with the postprandial reduction of TG.  Other putative mechanisms 
include hormonal changes (44), alterations in cellular homeostasis (45), and muscle 
contraction (43) may play a role in the exercise induced attenuation in TG following a HFM.  
The lower postprandial TG concentrations after exercise also reflect an enhanced rate of 
removal by peripheral tissues of TG-rich lipoproteins.  A decreased rate of VLDL synthesis 
and secretion from the liver is also a contributing factor and accounts, and may also play a 
role in reducing circulating postprandial TG (24). 
Postprandial lipemia and intermittent exercise 
A number of studies have examined the effect of exercise intensity and durations on 
attenuating the postprandial increase in plasma TG (25, 26).  Regardless of exercise duration 
and intensity, total energy expenditure (TEE) is the primary factor that influences PPL.  
Hardman(109) et al., compared the lipemic response to a standard OFTT consumed 16–18 h 
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following a moderate intensity (60% VO2 max) and low intensity (30% VO2max) exercise 
bout.  The moderate intensity exercise session resulted in a larger attenuation in 
postprandial TG-AUC when compared to the low intensity exercise.  When the duration of 
low intensity exercise was increased so that the TEE was identical to the moderate intensity 
trial, each bout of exercise reduced lipemia to the same degree. 
The energy expenditure can also be accumulated over a number of exercise sessions 
Gill et al., 1998 compared the accumulative effect of multiple short duration bouts of 
exercise to one continuous bout on PPL in healthy men.  Participants exercised on a 
treadmill at 60% VO2max in either one 90-min session (continuous exercise trial), or three 
30-min sessions at intervals of several hours (intermittent exercise trial).  Total caloric 
expenditure was similar in both trials.  The TG-AUC was similar in both trials, indicating that 
both intermittent and continuous exercise can similarly reduce PPL (109). 
The possibility of an accumulating benefit with multiple short bouts is particularly important 
for patients with PAD, as in many instances the disease restricts their ability to exercise for 
extended periods.  Individuals with PAD exhibit a postprandial lipid profile that is considered 
atherogenic, and also have an exaggerated postprandial lipemic response following a HFM.  
Based on findings from previous studies involving individuals with other forms of CVD, 
continuous and intermittent exercise may attenuate the postprandial response.  To date, no 
studies have examined the acute effects of exercise on PPL and endothelial function in men 
with PAD. 
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Inflammation and Exercise 
Inflammation plays an important role in the pathogenesis of cardiovascular disease. 
(Blum A, Miller HI. The role of inflammation in atherosclerosis. Isr J Med Sci 1996;32:1059–
1065.)  There is an inverse association between levels of physical activity and the blood 
concentration of inflammatory markers (Hammett et al 2006, Kohut et al 2006, Markovitch 
et al 2008, Plaisance et al 2007).  The mechanisms responsible for the decrease in the 
circulating levels of inflammatory biomarkers in response to exercise are not completely 
understood (Kohut et al 2006).  Inflammatory markers have been found to transiently 
increase after a single bout of high-intensity exercise (Markovitch et al 2008, Olson et al 
2007, Plaisance et al 2007).  This transient increase results in the subsequent up-regulation 
of anti-inflammatory pathways, such as CRP (Markovitch et al 2008).  Plaisance et al., (2007) 
found no significant change in the circulating levels of selected serum inflammatory markers 
in response to an acute bout of exercise at 70% VO2 (until they expended 500 kcal) in 21 
moderately/highly fit men.   
There is evidence that unhealthy individuals may express increased concentrations 
of inflammatory markers immediately post exercise (Plaisance et al 2007) and experience 
greater tissue damage.  Obese individuals often exhibit elevated levels of inflammatory 
markers (Olson et al 2007).  Waist circumference is positively associated (p<0.05) with 
baseline levels of CRP (Plaisance et al 2007).  Undertaking resistance training 2 times per 
week for I year had been shown to significantly increase lean body mass and significantly 
reduce the circulating levels of CRP in overweight women (Olson et al 2007).  Relatively 
Effect of Acute Exercise on Postprandial Lipemia and Endothelial Dysfunction in Men with Peripheral 
Arterial Disease 
__________________________________________________________________________________ 
31 
 
small increased in lean body mass may decrease circulating inflammatory markers (Olson et 
al 2007).   
Inflammatory biomarkers 
Inflammation plays an important role in the onset and development of 
atherosclerotic lesions (110,111).  C-reactive protein (CRP) is part of a group of substances 
known as “acute phase reactants” synthesised primarily by hepatic tissue, in response to 
tissue injury, including that caused by infection, malignant disease and chronic inflammatory 
conditions.  It plays an active role in vascular inflammation and development of 
atherosclerosis (112). Elevated levels of CRP increase the expression of cell adhesion 
molecules and interleukin-6 (IL-6).  CRP can also help facilitate LDL-C uptake by endothelial 
macrophages, (113-115) and decrease the expression of endothelial derived nitric oxide 
synthase (116).  CRP also increases the expression and activity of the serine protease 
inhibitor plasminogen activator inhibiter (PAI-1).   
Tumour necrosis factor alpha (TNF-α) is a proinflammatory cytokine produced by 
monocytes/macrophages (117), that is involved in the development of atherosclerosis.  TNF-
α stimulated the expression of adhesion molecules and IL-6, a major inductor of hepatic CRP 
synthesis (118).  High circulating levels of TNF-α increases the risk of recurrent events in 
stable post-myocardial infarction patients (119).   
Conclusion 
PAD affects 3-12% and IC affects 1-3% of the general population, (15, 16) and its 
prevalence increases significantly with age, affecting up to 20% of patients over the age of 
75 years.  Patients with PAD have an exaggerated PPL response to a HFM.  Exercise 
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attenuates the postprandial response to HFM in obese patients and those with CAD and 
diabetes.  To date, no studies have examined the acute effects of exercise on PPL and 
endothelial function in men with PAD. 
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Chapter 3  
METHODOLOGY 
Participants 
 Eight men ≥ 50 year with diagnosed PAD who had been participating in a community-
based phase IV cardiac rehabilitation programme, for a minimum of 6 months, were 
recruited.  Participants were excluded if they had a ratio of arm blood pressure to ankle 
blood pressure ≥ 0.95 at rest or ≥ 0.85 after exercise, Fontaine Stage III/Fontaine Stage II 
PAD (intermittent claudication upon ambulation) for  3 months, unstable angina, 
uncontrolled hypertension (systolic blood pressure (BP) >180 mmHg, diastolic BP >100 
mmHg), resting tachycardia, unstable/acute heart failure and in good health for a minimum 
of two weeks prior to beginning the study. 
Research Design 
 The study used a randomised cross-over design.  Participants visited the 
Cardiovascular Research Unit at Dublin City University on three occasions and involved one 
screening visit and two experimental trials.  They subsequently underwent two oral fat 
tolerance tests (OFTT) with a 4 h observation period, separated by approximately 7 d.  On 
the evening prior to the OFTT, the partcipants either rested at home (CON trial) or 
completed a 200 kcal treadmill walk (EX trial) at a self-regulated intensity.  Participants did 
not participate in the community-based phase IV cardiac rehabilitation program for 2 d 
before each experimental trial.  They recorded their normal diet the day prior to the first 
OFTT and repeated this diet on the day prior to the second OFTT.   
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Screening 
The nature and risks of the study were explained.  A plain language statement was 
read and informed consent was obtained in accordance with the Research Ethics Committee 
at Dublin City University.  Participants then completed a general health questionnaire 
(appendix D), and had their blood pressure, height and weight measured. 
Experimental Trials 
 Participants reported to the Cardiovascular Research Unit in DCU at 8 am following 
an overnight fast.  An intravenous catheter (21G) was inserted into a prominent forearm 
vein.  Following a 10 min rest period, a baseline blood sample was obtained.  Participants 
underwent (under supervision) an OFTT.  The test meal consisted of croissants, butter, 
chocolate and potato crisps with a macronutrient composition per 2m2 body surface area of 
38 g fat, 57 g carbohydrate, which amounted to a total meal count of 639 Kcal.  Water was 
consumed ad libitum following the first OFTT.  The volume of water consumed and the 
time(s) of consumption relative to the meal were recorded and replicated following the 
subsequent OFTT.  Blood samples were obtained before the test meal was ingested and in 
the postprandial period at 30, 60, 120, 180, and 240 min. Participants rested quietly during 
this period, but were permitted to read or watch television. 
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Acute Exercise Bout 
 Participants exercised on a treadmill (Woodway ELG 55, Waukesha,WI) at a self-
selected intensity until they expended 200 kcal.  The velocity and gradient control arrows 
were visible and participants were allowed to alter the treadmill grade and velocity ad 
libitum. A discontinuous protocol was used due to nature of PAD. Energy expenditure and 
exercise intensity were recorded continuously throughout the exercise bout.  Metabolic 
measurements were recorded throughout the exercise bout using open circuit spirometry 
(Sensormedics Vmax 229 metabolic system, SensorMedics Corp., Yorba Linda CA).   
Blood Pressure 
 Resting blood pressure was taken from a upright sitting position using a mercurial 
sphygmomanometer (Dekamet model Accoson Sphygmomanometers, Harlow Essex) and 
stethoscope (Classic II 3M Littmann, St. Paul, MN). 
Height and Weight 
 Height and body mass were measured to the nearest 0.1 cm and 0.1 kg 
respectively using the SECA Stadiomiter.  Participants were barefoot for the measurement. 
Overview of Endothelial Function Assessment 
 Flow mediated dilation (FMD) was assessed using high-resolution ultrasonography, 
by the same investigator, in a quiet, temperature-controlled room.  Ultrasound 
measurements were performed on a SonoSite MicroMaxx® (SonoSite Inc., Bothell, 
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Washington, US) ultrasound system with a linear array transducer (Figure 3.1), operating at 
a frequency of 12.0 MHz.   
 
Figure 3.1: SonoSite MicroMaxx® Ultrasound system and 12.0 MHz linear array transducer 
Participants arrived to the Vascular Research Unit, DCU at approximately 8.00 am after an 8 
h overnight fast.  Water consumption was permitted during the fasting period and where 
possible, all vasoactive medications were withheld for at least 4 half-lives.   
 All brachial artery images were acquired with the participants in a supine position.  
A baseline brachial artery image was acquired following a 10 min rest period and was 
immediately followed by assessment of FMD.  The right arm of the participant rested on an 
examination table perpendicular to the bed, and was extended and externally rotated to 
permit imaging of the right brachial artery.  An automated blood pressure cuff was placed 
on the right forearm, distal to the brachial artery (Figure 3.2) and electrodes for a 3-lead 
ECG were placed on their chest.  The ECG tracing was activated and settings adjusted to 
ensure clear identification of the R wave which corresponds to the end of diastole in the 
cardiac cycle.   
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  Figure 3.2:  Arm position and cuff placement. 
Ultrasound Technique and Image Acquisition 
 Anatomic landmarks such as veins and fascial planes were noted and used to 
ensure that all M-mode images and Doppler measurements were recorded at the same site. 
A longitudinal image of the brachial artery was obtained using B mode ultrasound.  The 
brachial artery was insonated 3-7 cm above the antecubital crease.  Great care was taken to 
maximize vessel diameter and provide optimal blood vessel wall definition.  Depth and gain 
settings were optimized to delineate the lumen-arterial interface optimally on both the near 
(anterior) and far (posterior) wall.  The boundaries were clearly visualized with the angle of 
insonation perpendicular to the vessel.  The imaging plane should bisect the vessel in the 
longitudinal direction to ensure diameter measurements obtained from these images 
reflect the true diameter of the vessel (Corretti et al., 2002).    
M mode Imaging 
 The brachial artery was imaged using M mode function to facilitate arterial 
diameter measurements at appropriate time points (figure 3.3).  The baseline brachial 
artery image was named and saved for subsequent off-line analysis of arterial diameter 
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using a custom-designed, semi-automated ultrasound arterial measurement software.  Each 
image acquired, incorporated a minimum of 2 ECG R waves.  The diameter of the brachial 
artery was measured at a minimum of two and maximum of three consecutive R waves on 
the ECG, a process referred to as “gating”.  The R wave represents the end of diastole in the 
cardiac cycle.  Gating allows diameter estimates to be taken at specified vertical cross-
sections of the artery.  The mean of the 2-3 measurements was taken as the brachial artery 
diameter.   
 
 Figure 3.3:  M mode ultrasound image of the brachial artery 
Doppler Imaging 
 Doppler imaging was used to measure blood flow velocity (cm/s) in the brachial 
artery.  The Doppler scale was adjusted to accommodate the spectral signal and the 
expected increase in blood flow following cuff release.  The scale was maintained at the 
minimum range to decrease measurement error.  The Doppler gate was set to minimum 
(1.5 mm) and was positioned in the center of the artery lumen.  The Doppler gate was 
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aligned with the direction of flow and the transducer was adjusted to achieve an angle of 
60.  The insonation angle between the pulsed-wave Doppler beam and the vessel walls was 
adjusted by manipulation of the transducer, to allow the beam to be steered and the angle 
corrected in alignment with the vessel orientation/parallel, and blood flow axis at a discrete 
segment of vessel 60.  The Doppler function traced the spectral wave form (Figure 3.4).  
The investigator froze the image and peak systolic velocity was manually measured using 
the in-built ultrasound calipers (SonoSite MicroMaxx®). The “Doppler” function traced the 
spectral wave form.   
 
 
 Figure 3.4:  Frozen screen shot of a Doppler image 
Endothelial-Dependent Dilation (EDD) 
 Figure 3.5 illustrates the endothelial-dependent dilation assessment protocol.  
After baseline measurements were recorded, the pneumatic cuff was inflated to 250 mmHg 
for 5.0 min.  Following 5 min of occlusion, the cuff was rapidly released resulting in reactive 
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hyperemia of the hand and a subsequent increase in brachial artery blood flow.  Post-
deflation peak systolic velocity was measured within 15 seconds of cuff release and vessel 
diameter was recorded to allow calculation of hyperaemic flow.  M-mode images of the 
brachial artery were named and recorded every 30 sec post-deflation for 5 min.  These 
images were saved for post-analysis, using a custom-designed, semi-automated ultrasound 
arterial measurement software.  
 
Figure 3.5:  Overview of the protocol used to assess endothelial dependent dilation  
Endothelial Independent Dilation (EID) 
 Figure 3.6 illustrates the endothelial-independent dilation assessment protocol 
after a resting period of 15 min post-deflation; the brachial artery was imaged using M-
mode ultrasound.  This image was named and recorded as a new baseline.  Participants 
were administered with a single spray of sublingual gylceryl trinitrate (GTN) (400 g).  M-
mode images of the brachial artery were once again named and recorded every 30 sec post 
GTN for 5 min.  Similarly, images were saved for post-analysis. 
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Figure 3.6: Overview of the protocol used to assess endothelial independent dilation 
All images were selected for analysis using a standard dialog box (Figure 3.7).  For 
each image, the artery was located and the area between the anterior and posterior arterial 
walls was manually selected.  The software used this point to segment the arterial boundary 
using a constrained region-growing algorithm, and the result was depicted visually in that 
the segmented arterial lumen was highlighted using grey shading.  The segmentation of the 
artery was updated in real-time.  The automated values could be overridden by selecting a 
new seed point or using a slider to change the threshold intensity values of the 
segmentation.   
 
Figure 3.7: Standard dialog box 
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Gated measurements of the brachial artery diameter were recorded using a 
minimum of two and maximum of 3 consecutive R waves on an ECG.  The mean of the 2-3 
measurements was taken as the brachial artery diameter.   
Cardiorespiratory and Metabolic Measures  
 Expired air was collected continuously during the exercise bout for determination 
of   O2 and   CO2 via a breath by breath metabolic system (Sensormedics Vmax 229, 
SensorMedics Corp., CA).  Prior to testing, the gas analysers were calibrated with standard 
gases of known concentration.  Energy expenditure and substrate oxidation was estimated 
using indirect calorimetry. 
 Energy expenditure during the acute bout of exercise was calculated using the 
equation of Weir:134 EE (kJ.min-1) = 16.5   O2 (L.min
-1) + 4.63   CO2 (L.min
-1).  The rate of 
carbohydrate and fat oxidation was calculated from gas exchange measurements according 
to the table of non-protein respiratory quotient:135  CHO oxidation = 4.85 x   CO2 – 3.226 x 
  O2, and lipid oxidation = 1.695 x   O2 - 1.701 x   CO2, with mass expressed in g.min
-1 and 
gas volume in L.min-1.  The percentage of carbohydrate and lipid oxidation during exercise 
was calculated using the McGilvery & Goldstein equations:136  [%lipid oxidation = ((1-
RER)/0.29) x 100, and %CHO oxidation = ((RER-0.71)/0.29) x 100.  Values for   O2,   CO2 and 
RER were averaged every minute throughout the exercise period. 
Mass Flow Sensor Heated wire Anemometer - Mode of Operation  
 A mass flow sensor (Sensormedics, Loma Linda, CA, USA) was used to collect 
breath-by-breath measurement of ventilation.  The mass flow sensor is a low resistance 
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tube with a tapered internal diameter extending from both ends of a laminar flow throat. A 
cold and hot stainless steel wire electrically heated to -180°C and -240°C respectively, are 
centered in the flow stream.  These wires are elements in a servo-controller bridge circuit 
that maintain the resistance ratio of the two wires at a constant value.  If only the 
temperature of the inspired gases change, then both wires lose heat at the same rate and 
no current change is required to keep the bridge balanced.  As air flows across the wires, 
the hot air loses heat more rapidly than the cold air and the current must be added to keep 
the bridges balanced at a 3:4 ratio.  The amount of current required is proportional to the 
mass flow of the gas.  This method ensures that the sensor measures only the heat loss 
from the molecular convection of the moving gas stream, and not the artefact due to 
cooling of the gas as it passes through a breathing assembly.  The mass flow meter responds 
to instantaneous flow rates between 0-16 L.sec-1 and integrated flow between 0-350 L.min-
1 with flow resistance <1.5 cmH2O.L-1.sec-1.  The mass flow sensor was outputted to the 
analyser module of the Vmax 229 and was sampled at a rate of 125 Hz.  
Mass Flow Sensor Calibration  
 A 3 L volume syringe (Sensormedics, Loma Linda, CA, USA) was used to calibrate 
the mass flow sensor prior to each test. The syringe was connected to the mass flow sensor, 
and stroked four times in order to measure inspired and expired volumes. The volumes 
were calculated by expressing 3 L as a fraction of each measured inspired and expired 
volume achieved during calibration. An average correction factor was calculated for inspired 
and expired volumes, and used to fine tune the volume measurement. A verification 
procedure was performed. This involved stroking the 3 L volume syringe four times. Inspired 
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and expired volumes were measured using the newly calculated correction factors. In order 
to pass the calibration procedure, one of the four strokes had to have an average flow rate 
< 0.5L.sec-1, and at least one of the four strokes had to have an average flow > 3.0L.sec-1.  
Gas Analysers  
 The Vmax 229 utilizes a rapid response infrared measurement technique. An O2 
and CO2 analyzer is integrated with the Vmax 229. A small sample of inspired air is drawn 
through a sample cell, and exposed to an infrared light through an optical that it passed 
through a band pass filter and the sample cell. An infrared detector responds to the amount 
of infrared light that passes through the sample cell. The amount of light that passes 
through the sample cell varies according to the concentration of CO2 in the sample cell. 
Based on measured levels of infrared light intensity, the analyzer computes the PCO2 in the 
gas sample. The CO2 analyzer is linearly scaled across the 0-100% range with a resolution of 
0.01% CO2, and a response time of < 130ms (10-90%) at 500ml.min
-1 flow. The O2 analyzer is 
based on the high paramagnetic susceptibility of O2. A diamagnetic glass dumbbell 
suspended in a magnetic field rotates in proportion to the PO2. The analyzer is linearly 
scaled across the 0-100% range with a resolution of 0.01% O2 and a response time of < 
130ms (10-90%) at 500ml.min-1 flow.  
Calibration of CO2and O2 Analyzers  
 The gas analyzers were calibrated with standard gases of known concentration 
(BOC gases, Dublin, Ireland). The first calibration gas contained 26.00±0.02% oxygen (O2) 
and the balance nitrogen (N2). The second calibration gas contained 4.00±0.02% carbon 
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dioxide (CO2), 16.00±0.02% O2, and the balance N2. A small bore drying tube connected to 
the CO2 and O2 analyzers sampled the calibration gases. The absorption and evaporative 
properties of the drying tube ensured that the relative humidity of the calibration gas was 
equilibrated to ambient conditions prior to sampling by the O2 and CO2 analyzers. The 
calibration gas was sampled at a rate of 125 Hz. The response time was similar between O2 
and CO2 analyzer.  
Blood Sampling and Processing 
 Blood samples were collected into vacutainers containing either potassium EDTA or 
without any additive (Becton Dickinson and Co., UK).  Serum was separated by 
centrifugation (1620 g for 15 min at 4 ºC) (PK121R centrifuge, ALC, VA) within 30 min of 
collection.  Plasma and Serum samples were stored at -80C.  Repeated measures from all 
subjects were defrosted together and analysed in the same run. 
Biochemical Assays 
 Immediately following collection, a complete blood count was performed on whole 
blood samples drawn at baseline, 30 min, 60 min, 120 min, 180 min, 240 min in an EDTA-
coated tube using an automatic hematology analyser (Ac-T Diff 2, Beckman Coulter, CA). 
Serum total cholesterol, TG, HDL-C, LDL-C and high-sensitivity CRP were determined using 
enzymatic assays (Randox laboratories, Northern Ireland).  Commercially available enzyme-
linked immunoassays (R&D Systems, UK) were used to determine plasma TNF-α. Intra-assay 
coefficient of variation was 8.1%. 
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Statistical Analysis 
 Statistical analysis was performed using SPSS 19.0 computer software (SPSS, Chicago, 
IL).  The dependent variables were EDD and EID, TG, total cholesterol, HDL-C, LDL-C, 
leukocytes, hsCRP, and TNF-.  A mixed model (time x experimental condition) repeated 
measures ANOVA was used to compare changes in endothelial function, blood lipids, 
leukocytes and inflammatory markers.  Where indicated by a significant F value, post hoc 
tests, with a Bonferroni correction for multiple comparisons, was performed to compare 
specific group means.  Data are presented as mean ± standard deviation. A probability of p ≤ 
0.05 was accepted for statistical significance. 
 Summary postprandial responses to the test meal are reported as time-averaged 
postprandial values (Appendix B) using the approach of Gill et al (2006).  Time-averaged 
postprandial values represent the total area under the concentration vs. time curve (AUC), 
calculated using the trapezium rule, and divided by the length of the postprandial period.  
The TG increment (Appendix B) represents the AUC above baseline, divided by the length of 
the postprandial period. 
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Chapter 4  
RESULTS 
 Participant’s physical characteristics are summarized in Table 1.  Participants were 
classified as being overweight and borderline hypertensive.  Fasting concentrations of total 
cholesterol, HDL-C, LDL-C and TG were within the normal range.  The total caloric count of 
the meal was 639.5 ± 35.3 Kcal and consisted of 38.1 ± 2.2 g of fat and 57.0 ± 3.5 g of 
carbohydrate.  Participants exercised for 38.0 ± 3.6 min and expended 195.2 ± 8.8 kcal·hr-1 
during the acute bout of intermittent exercise.  The treadmill velocity and gradient was 4.7 ± 
0.3 km·hr-1 and 0.9 ± 0.1%, respectively.  Total oxidation of carbohydrate was 0.63 ± 0.10 
g/min and fat was 0.25 ± 0.04 g/min. 
Triglycerides 
 Circulating TG levels were significantly higher (p<0.05) in both the exercise and 
control trials at 120 min, 180 min  and 240 min compared to baseline (Figure 4.1).  There 
was no significant difference in TG at any time points between the exercise and control trial.  
The TG-AUC was 12% lower in the exercise than the control trial (7.1 vs 8.1 mmol/L).  This 
difference did not however reach statistical significance.  There were no within or between 
trial differences in total cholesterol, LDL-C or HDL-C at any time point (Table 2). 
Inflammatory Markers 
 Compared to baseline, circulating leukocytes were significantly higher (p<0.05) in 
both the exercise and control trial at 120 min, 180 min and 240 min.  There was no 
significant difference in leukocyte number between the exercise and control trial at any 
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time point during the study.  Plasma levels of hsCRP did not change in response to the OFTT 
during the control or exercise condition.  Plasma concentrations of TNF-α were significantly 
higher (p<0.05) than baseline at 120 min, 180 min and 240 min following the OFTT in both 
the exercise and control trials.  There was no significant difference in plasma concentrations 
of TNF-α between the exercise and control trial at any time point.   
Endothelial Function 
 FMD results are presented in figure 4.4.  A significant main effect for condition 
(P<0.05) was observed but there was no significant condition-by-time interaction.  There 
was a significant decrease (p<0.05) in FMD 2 h postprandial in both conditions.  There was 
no significant difference due to the exercise condition.  There was no significant difference 
in endothelial-independent dilation in ether condition.  A significant percentage increase 
(p<0.05) was observed in brachial artery Doppler flow between 2 h and 4 h postprandial in 
the control trial.  Endothelial dependent dilation (EDD) and endothelial independent dilation 
(EID) were not significantly different between the groups. 
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 Table 4.1: Subjects physical characteristics (n=8) 
Values are mean ± SD 
  
Age (yrs) 62.3 ± 2.4 
Height (cm)  167.9 ± 8.9 
Body mass (kg·m-2) 28.8 ± 3.4 
Ankle Brachial Index 0.6 ± 0.1 
Body surface area (m2) 1.9 ± 0.1 
Systolic BP (mmHg)  138.0 ± 7.8 
Diastolic BP (mmHg) 84.9 ± 3.6 
Cholesterol (mmol/L-1) 5.0 ± 1.1 
HDL-C (mmol/L-1) 3.0 ± 1.4 
LD-C (mmol/L-1) 1.3 ± 0.2 
Triglycerides (mmol/L-1) 1.1 ± 0.5 
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Table 4.2: Effect of acute exercise on lipids and inflammatory biomarkers  
 Control (n=8)  Exercise (n=8) 
 0 h 4 h  0 h 4 h 
Total cholesterol (mmol.L-1) 4.8 ± 1.2 4.9 ± 1.1  5.0 ± 1.2 4.8 ± 1.1 
LDL-cholesterol (mmol.L-1) 1.2 ± 0.2 1.1 ± 0.2  1.2 ± 0.3 1.1 ± 0.2 
HDL-cholesterol (mmol.L-1) 3.0 ± 1.1 2.8 ± 1.1  3.0 ± 1.3 2.9 ± 1.1 
TG (mmol.L-1) 1.2 ± 0.5 2.6 ± 0.8*  1.1 ± 0.4 2.1 ± 0.8* 
CRP (mg.L-1) 3.5 ± 2.3 3.5 ± 2.4  3.6 ± 2.0 3.4 ± 2.1 
TNF-α (pg.mL-1) 2.4 ± 1.2 2.6 ± 1.2*  2.4 ± 1.1 2.7 ± 1.2* 
WBC (cells x 10e3.μL-1) 6.8 ± 1.3 8.3 ± 1.5*  6.9 ± 1.1 8.1 ± 0.8* 
Values are mean ± SD; *p<0.05 vs. 0 h (within group) 
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Figure 4.1   Circulating levels of TG in the postprandial period following the control and 
exercise trial.  Values are mean ± SD; *P<0.05 vs. baseline in exercise and 
control trial 
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Figure 4.2 Circulating leukocytes in the postprandial period following the control and 
exercise trial.  Values are mean ± SD; *P<0.05 vs. baseline in exercise and 
control trial 
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Figure 4.3.  Circulating levels of TNF-α in the postprandial period following the control 
and exercise trial.  Values are mean ± SD; *P<0.05 vs. baseline in exercise and 
control trial 
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Figure 4.4 Brachial artery flow mediated dilation in control and exercise trial before the 
HFM, and 2 h and 4 h following the HFM.  Values are mean ± SD; *P<0.05 vs. 
baseline in exercise and control trial  
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Chapter 5  
DISCUSSION 
Postprandial lipemia (PPL) is characterized by an increase in triglyceride-rich 
lipoproteins for up to 8 h following the consumption of a HFM.  Regular exposure to high 
postprandial TG concentrations is positively associated with atherosclerosis through its 
adverse effect on vascular integrity and inflammation.1. Epidemiological studies also 
indicate that elevated postprandial lipemia is an independent predictor of CVD2.   
Reducing the accumulation of TG rich lipoproteins during the postprandial period 
presents a viable target for lowering arteriosclerotic risk.  The benefits of aerobic exercises 
in acute PPL have been documented in several studies (11, 100, and 120).  Several exercise 
variations have been tested, such as light, moderate and intense continuous and 
intermittent exercises.  To date, no studies have examined the effect of exercise on PPL in 
patients with PAD.  It was hypothesised that in men with PAD, an acute exercise bout would 
reduce the postprandial TG response, decrease circulating levels of inflammatory markers 
and preserve brachial artery FMD in response to a standardised HFM. 
 The major findings of the present study are that acute exercise does not i) attenuate 
the PPL in response to a HFM in patients with PAD, and ii) ameliorate the reduction in 
brachial artery FMD in response to a HFM, or iii) alter the endothelial independent 
                                                          
1
 Patsch, J. R., Miesenböck, G., Hopferwieser, T., Mühlberger, V., Knapp, E., Dunn, J. K., Gotto, A. M. and 
Patsch, W. (1992) Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial 
state. Arterioscler. Thromb. 12, 1336-1345 
2
 estgaard, B. G., Benn, M., Schnohr, P. and Tybjaerg-Hansen, A. (2007) Nonfasting triglycerides and risk of 
myocardial infarction, ischemic heart disease, and death in men and women. JAMA, J. Am. Med. Assoc. 298, 
299-308 
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vasomotor responses.  These findings may be partly explained by the fact that the total 
caloric expenditure (200 kcal) may have been insufficient to induce a significant decrease in 
PPL.  Previous studies that have found an attenuated postprandial response to a HFM 
involved moderate to vigorous levels of exercise at 60% VO2max that resulted in a caloric 
expenditure between 600 – 900 kcal (1,109).  The functional limitations associated with PAD 
precluded these individuals from undertaking a prolonged bout of exercise that would be 
sufficient to meet the caloric threshold required to attenuate the PPL response to a HFM.  It 
was not possible to assess the relative metabolic demand during exercise due to the fact 
that participants were unable to undertake a maximal exercise test.  However, the fact that 
the mean treadmill walking velocity was 4.7 km·h-1 would indicate that the exercise intensity 
was light to moderate.  Pilot work, prior to the study indicated that on average, PAD 
patients were only able to sustain discontinuous exercise at light to moderate levels of 
activity for > 30 min. 
 Postprandial TG levels were similar in both the exercise and control trials up to 3 h.  
The fact that TG levels began to decrease towards baseline values at 4 h in the exercise 
group, but were still rising in the control group, suggests a delayed clearance of TG, in the 
control trial.  The TG-AUC pattern was similar to that found in other studies that compared 
the effect of an acute bout of exercise on postprandial TG-AUC (120, 121).   
 Impaired EDD has been linked to the pathogenesis of atherosclerotic vascular 
diseases and acute cardiovascular events.  A number of previous studies have found a 
transient impairment in endothelial vasomotor function in response to a high fat meal 
(HFM) (1).  An acute bout of exercise performed prior to HFM can ameliorate this 
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impairment in endothelial vasomotor function (112).  In the present study, brachial artery 
FMD was impaired for 4 h following consumption of a single HFM, and acute exercise had no 
effect on the FMD response.  In fact, there is evidence that a single bout of exercise can 
transiently impair brachial artery FMD in patients with PAD.  Elevated TG increases 
superoxide anion production and may reduce endothelial vasomotor function through 
direct inactivation of NO and increases in lipid oxidation (123). 
 In patients with PAD, calf-pain during walking, followed by a period of rest to allow 
reperfusion of the ischemic limb, induces an increase in oxidative stress and a marked 
inflammatory response (63,64).  Oral administration of vitamins C and vitamin E ameliorates 
the decrease in endothelial function in response to a HFM in healthy individuals (96) 
indicating that an oxidative stress mechanism may be responsible for the impaired 
endothelial function after a HFM (21).   
 The increase in circulating levels of WBC and TNF-α at 4 h following a HFM are 
consistent with a number of previous studies (1,124), and have been shown to contribute to 
a pro-inflammatory environment.  The inflammatory response in the postprandial state was 
not attenuated by acute exercise.  Previous studies that have investigated the effects of a 
HFM on plasma levels of TNF-α have been equivocal.  A study by Esposito et al., (125) found 
that a single HFM further impaired endothelial function in individuals with the metabolic 
syndrome, and increased TNF-α levels were significantly related to this impairment.  In 
contrast, others have found no change in TNF-α levels following a HFM.  Gill et al., (126) 
found that the decrease in endothelial function in the cutaneous microcirculation after a 
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HFM was not associated with increased circulating levels of TNF-α.  However, this study 
involved endurance-trained athletes, and may not be representative of patients with CVD.   
 CRP is linked to endothelial cell activation (112).  Studies examining CRP responses 
after an acute bout of exercise have used strenuous and prolonged activity bouts (112,114).  
A single session of exercise triggers an increase in circulating levels of CRP.  There was no 
change in CRP at 4 h after the OFTT in either condition, in the present study.  It is possible 
that the acute inflammatory response was much lower when compared to studies that used 
prolonged and/or high intensity exercise. 
Study Limitations 
 The most accurate method for normalizing FMD responses is believed to be the area 
under the curve shear response from post-occlusion to the time at which peak 
diameter occurs.  Presently, the Vascular Research laboratory in DCU is not equipped 
to measure viscosity and the ultrasound system does not have the functionality for 
simultaneous acquisition of B-mode diameter and pulsed-wave Doppler velocity 
signals, or the continuous measurement of blood flow velocity.  Duplex ultrasound 
for simultaneous capture is recommended where available. For these reasons shear 
rate was calculated as an accepted estimate of shear stress, using peak blood flow 
velocity (equation: shear rate = 4*peak velocity/peak diameter)  
 Due to dropouts only 8 participants completed the research study 
Conclusion 
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 In summary, the present study found that an OFTT significantly increases post 
prandial TG, leukocytes and TNF-α and significantly reduces brachial artery FMD in men with 
PAD.  An acute bout of discontinuous exercise that resulted in a 200 Kcal expenditure does 
not attenuate the post prandial TG response or ameliorate the decrease in endothelial 
vasomotor function.   
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Chapter 6  
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APPENDIX A 
 
This application form is to be used by researchers seeking ethics approval for individual 
projects and studies. The signed original and an electronic copy of your completed 
application must be submitted to the DCU Research Ethics Committee.   
 
NB - The hard copy must be signed by the PI.  The electronic copy should consist of one file 
only, which incorporates all supplementary documentation.  The completed application 
must be proofread and spellchecked before submission to the REC.  All sections of the 
application form should be completed.  Applications which do not adhere to these 
requirements will not be accepted for review and will be returned directly to the 
applicant. 
 
Applications must be completed on the form; answers in the form of attachments will not 
be accepted, except where indicated.  No handwritten applications will be accepted.  
Research must not commence until written approval has been received from the Research 
Ethics Committee. 
 
 
 
 
Dublin City University 
RESEARCH ETHICS COMMITTEE 
 
APPLICATION FOR APPROVAL OF A PROJECT INVOLVING HUMAN 
PARTICIPANTS 
 
Application No. (office use only)  DCUREC/2010/   
 
Period of Approval (office use only) ....../....../...... to
 ....../....../.... 
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PROJECT TITLE Effect of Acute Exercise on Postprandial Lipemia in Peripheral Arterial 
Disease 
 
PRINCIPAL 
INVESTIGATOR(S) 
Prof. Niall M. Moyna 
 
 
Please confirm that all supplementary information is included in your application (in both 
signed original and electronic copy). If questionnaire or interview questions are submitted in 
draft form, a copy of the final documentation must be submitted for final approval when 
available. 
 
 INCLUDED NOT 
APPLICABLE 
Bibliography    
Recruitment advertisement    
Plain language statement/Information Statement    
Informed Consent form    
Evidence of external approvals related to the 
research 
   
Questionnaire  
draft 
 
final 
 
Interview Schedule  
draft 
 
final 
 
Debriefing material     
Other    
 
 
Please note: 
 
1. Any amendments to the original approved proposal must receive prior REC approval. 
 
2. As a condition of approval investigators are required to document and report 
immediately to the Secretary of the Research Ethics Committee any adverse events, 
any issues which might negatively impact on the conduct of the research and/or any 
complaint from a participant relating to their participation in the study 
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Please submit the signed original, plus the electronic copy of your completed application to:  
Ms. Fiona Brennan, Research Officer, Office of the Vice-President for Research  
(fiona.brennan@dcu.ie, Ph. 01-7007816) 
 
1. ADMINISTRATIVE DETAILS 
 
 
THIS PROJECT IS:  Research Project  Funded Consultancy 
(tick as many as 
apply) 
 Practical Class  Clinical Trial 
  Student Research Project  
(please give details) 
 Other  - Please Describe:       
  Resear
chMast
ers 
 Taught Masters 
  PhD  Undergraduate 
 
Project Start 
Date: 
01/02/11 Project End 
date: 
01/07/12 
 
 
1.1 INVESTIGATOR CONTACT DETAILS (see Guidelines) 
 
PRINCIPAL INVESTIGATOR(S):  
 
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Prof Moyna Niall 01 
7008802 
01 7008888 niall.moyna@dcu.ie 
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OTHER INVESTIGATORS: 
 
TITLE SURNAME FIRST NAME PHONE FAX EMAIL 
Dr. Mc Caffrey Noel      087 
2797597 
 
01 7008888 
 
noel.mccaffrey@dcu.ie 
 
Dr.  Woods Catherine      01 7008008 
 
01 7008888 
 
catherine.woods@dcu.ie 
 
Dr. Murphy Ronan 01 7008824 
 
01 7008888 
 
ronan.murphy@dcu.ie 
 
Ms.  Hughes Sarah      086 
8673608      
01 7008888 
 
sarah.hughes3@mail.dc
u.ie 
 
Ms. Furlong Bróna 086 
3687961 
 
01 7008888 
 
brona.furlong2@mail.dc
u.ie 
 
Mr. Kevin O’Hara 085 
1687637 
01 7008888 kevin.ohara2@mail.dcu.i
e 
 
FACULTY/DEPARTMENT/SCHOOL/ 
CENTRE: 
(NB – if Nursing, please note all students 
including PhD’s must attach the letter from 
the Nursing Ethics Advisory Committee to 
this application) 
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1.2 WILL THE RESEARCH BE UNDERTAKEN ON-SITE AT DUBLIN CITY UNIVERSITY? 
 
 YES  NO (If NO, give details of off-campus location.) 
      
 
1.3 IS THIS PROTOCOL BEING SUBMITTED TO ANOTHER ETHICS COMMITTEE, OR HAS IT 
BEEN PREVIOUSLY SUBMITTED TO AN ETHICS COMMITTEE?) 
 
 YES  NO (If YES, please provide details and copies of approval(s) 
received etc.)   
 
 
DECLARATION BY INVESTIGATORS 
The information contained herein is, to the best of my knowledge and belief, accurate.  I 
have read the University’s current research ethics guidelines, and accept responsibility for 
the conduct of the procedures set out in the attached application in accordance with the 
guidelines, the University’s policy on Conflict of Interest and any other condition laid down 
by the Dublin City University Research Ethics Committee or its Sub-Committees.  I have 
attempted to identify all risks related to the research that may arise in conducting this 
research and acknowledge my obligations and the rights of the participants. 
 
If there any affiliation or financial interest for researcher(s) in this research or its outcomes 
or any other circumstances which might represent a perceived, potential or actual conflict of 
interest this should be declared in accordance with Dublin City University policy on Conflicts 
of Interest.  
 
I and my co-investigators or supporting staff have the appropriate qualifications, experience 
and facilities to conduct the research set out in the attached application and to deal with 
any emergencies and contingencies related to the research that may arise. 
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Signature(s): 
 
Principal investigator(s):      
 
 
Print name(s) in block letters:  Niall M. Moyna 
 
Date:   01/12/10 
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2. PROJECT OUTLINE  
2.1 LAY DESCRIPTION 
High levels of fat in the blood following a meal can impair the ability of blood vessels 
to function properly.  A single session of exercise that occurs 4-24 hours prior to a 
high fat meal can substantially reduce the subsequent increase in the amount of fat 
in the blood.  Whether the impaired ability of blood vessels to function properly can 
be reduced with an acute bout of exercise has not been extensively investigated in 
patients with peripheral arterial disease (PAD).  The purpose of this study is to 
investigate if a single bout of exercise prior to feeding can counteract the 
impairment in blood vessel function following a high fat meal in patients with PAD. 
2.2 AIMS OF AND JUSTIFICATION FOR THE RESEARCH  
The vascular endothelium is a primary target for injury from mechanical forces and 
processes related to cardiovascular risk factors including, aging, hypertension, 
dyslipidemia impaired fasting glucose, insulin resistance and smoking.  Vascular 
injury provoked by pathophysiological stimuli reduces the bioavailability of 
endothelium-derived NO resulting in endothelial dysfunction.  This in turn 
contributes to lesion development through inflammation, vasoconstriction, smooth 
muscle cell proliferation, platelet activation, leukocyte adhesion, mitogenesis, pro-
oxidation impaired coagulation, and thrombogenesis.  There is now accumulating 
evidence that endothelial dysfunction represents one of the earliest events in the 
pathogenesis of cardiovascular disease.   
The available evidence suggests that high levels of circulating triglycerides in 
response to a fatty meal (postprandial triglycerides) impairs endothelial function for 
up to 6 h (Gaenzer et al. 2001; Plotnick et al. 1997; Vogel et al. 1997).  Since a 
significant part of the day is spent in the postprandial state (Sies et al. 2005), 
strategies that counteract this state may be effective in preventing cardiovascular 
disease.  A single bout of prolonged exercise that occurs 4-24 hours prior to feeding 
can reduce postprandial triglycerides.  This acute effect typically results in a 20-30% 
reduction in the area under the triglyceride-time curve.  To our knowledge no 
studies have examined the efficacy of a single exercise bout in attenuating 
postprandial lipemia and endothelial dysfunction in patients with peripheral arterial 
disease.  The purpose of this study is to investigate if a single bout of exercise prior 
to feeding can counteract the postprandial impairment on endothelial function in 
patients with PAD. 
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2.3  PROPOSED METHOD  
 Overview 
The study will take place in Dublin City University.  Subjects will visit the Vascular 
Research Unit (VRU) in the School of Health and Human Performance on 4 separate 
occasions.  During the first visit subjects will undergo a brief physical examination, 
have their body composition assessed and perform a treadmill exercise test.  The 
second and third visit will take place within 12-14 h of each other.  Subjects will visit 
the VRU between 6 and 7 pm to undertake a bout of exercise (visit 2).  Subjects will 
return to the VRU the next morning to undergo a 4 h oral fat tolerance test (visit 3).  
On the evening prior the fourth visit the subjects will rest quietly at home and visit 
the VRU the next morning to undergo a 4 h oral fat tolerance test.  Subjects will 
consume their normal diet for 2 d before and will not undertake strenuous physical 
activity for 24 h prior to each oral fat tolerance test (OFTT).  They will fast for 12 h 
before the OFTT.  Blood sample will be taken and endothelial function will be 
assessed at regular intervals for 4 hours. 
Visit 1:  The nature and risks of the study will be explained, and informed consent 
will be obtained.  Subjects will undergo a brief physical examination.  The treadmill 
test will involve an incremental walking to volitional fatigue (2mph: 0%grade, 
increasing 2% every 2min until absolute claudication distance).  A physician will be 
present during the test.  Subjects will wear a mouthpiece or facemask during the test 
to familiarize them with the equipment.  A 12 lead ECG will be used to continuously 
monitor the electrical activity of the heart.  Rating of perceived exertion will be 
measured every min.   
Visit 2:  During the second visit subjects will walk on a treadmill at a self selected 
intensity until they expend 300Kcal within 1hr. The treadmill exercise will be 
undertaken by having the subjects exercise until claudication symptoms develop, 
then rest until symptoms subside.  The exercise-rest cycle will be repeated until the 
subjects expend 300 kcal.  Subjects will wear a mouthpiece or facemask during the 
test to measure caloric expenditure.  Heart rate will be continuously measured and 
rating of perceived exertion will be recorded every 5 min. 
Visit 3: Oral fat tolerance tests   
Subjects will visit the VRU between 8-10 am the following morning in a fasted state.  
An intravenous catheter will be inserted into a forearm vein and a fasting blood 
sample obtained (0 h).  This catheter will kept patent during the 4 h postprandial 
follow-up period by flushing regularly with a 0.9% saline solution.  Endothelial 
dependent dilation (EDD) and endothelial independent dilation (EID) will then be 
measured.  The test meal will consist of a macronutrient composition per 2m2 body 
surface area of 97 g fat, 124 g CHO and 1450 kcal.  Subjects will rest quietly in the 
laboratory during the observation period with blood sampled at 0.5, 1, 2, 4h 
postprandially.  Endothelial function will be measured at 0.5, 2, and 4hr.  
Visit 4:  On the evening prior the fourth visit the subjects will rest quietly at home 
and visit the VRU the next morning to undergo a 4 h oral fat tolerance test.  Subjects 
will undergo the same experimental protocol as described for visit 3.  
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Dietary Control   
Subjects will be required to abstain from alcohol and not to engage in exercise or 
heavy physical work, for 3 d prior to each OFTT.   On the day prior to each OFTT, diet 
will bestrictly controlled with subjects consuming 3 meals provided by the 
laboratory.  The meals will be individualized to provide an energy content equal to 
1.4 times BMR, with 56% as CHO, 30% as fat and 30% as protein.  BMR will be 
estimated from the Harris-Benedict equation (12).  On the two days prior to this, 
subjects will consume their normal diet.  Food items consumed along with portion 
size will be recorded on sheets provided, prior to the first OFTT.  This diet was then 
replicated in advance of the second OFTT. 
Brachial Artery Reactivity (BAR):  
Endothelial dependent dilation will be determined in response to reactive hyperemia 
following 5 min of lower arm occlusion.  A blood pressure cuff will be placed on the 
left arm for blood pressure monitoring and another on the right lower arm for 
occlusion.  ECG leads will be attached to monitor heart rate.  Subjects will rest for 10 
min in a supine position.  Blood pressure will be determined during the final 2 
minutes of the rest period.  Baseline blood flow and brachial artery diameter 
(SonoSite, MicroMaxx) will be recorded.  The right arm blood pressure cuff will then 
be inflated to approximately 220-230 mmHg and maintained at that pressure for 5 
minutes.  The cuff will then be rapidly deflated after 5 min of occlusion.  Doppler 
blood flow measurement will be obtained during the first minute following cuff 
deflation.  Brachial artery diameter will be assessed at one and three minutes post 
occlusion.  Subjects will then rest for 15 minutes to eliminate endothelium 
dependent effects on brachial artery diameter.  After this period, endothelial 
independent dilation will be assessed.  Baseline blood flow and brachial artery 
diameter will be recorded and used as a baseline prior to sublingual nitroglycerine 
administration.  Nitroglycerin (0.4mg) will be placed under the subjects tongue.  
Doppler blood flow measurement will be obtained three minutes following the 
sublingual nitroglycerin administration and brachial artery diameter measurements 
will be assessed 3 and 5 minutes post nitroglycerin administration.   
2.4 PARTICIPANT PROFILE  
Men and women aged ≥ 40 yr with diagnosed PAD, who have been referred to the 
SmartSteps programme by the vascular surgeons in Beaumont Hospital and the 
Mater Misericordiae Hospital will be recruited.   
Inclusion Criteria: 
 Referred by the vascular departments in Beaumont Hospital and The Mater 
Hospital  
 Stable angina 
 Ratio of arm blood pressure to ankle blood pressure  <0.95 at rest or <0.85 
after exercise 
 Fontaine Stage II PAD (intermittent claudication upon ambulation) for > 3 
months 
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 Clinically stable and in good health for a minimum of two weeks prior to 
beginning the study 
 
Exclusion Criteria:   
 Fontaine Stage I PAD (ambulation not limited by claudication) 
 Fontaine Stage III PAD (pain at rest) 
 Ulceration or gangrene 
 Vascular surgery or angioplasty in past 6 months 
 Co-morbidities contradictive to exercise 
 Factors other than intermittent claudication limiting exercise tolerance  
 Diabetes mellitus 
 Unable to walk on a treadmill 
 Current smoker 
 Unstable angina 
 Systolic  blood pressure >180 mmHg and/or diastolic blood pressure > 
100 mmHg 
 Resting tachycardia   
 Unstable or acute heart failure 
2.5 MEANS BY WHICH PARTICIPANTS ARE TO BE RECRUITED  
Men and women referred to the SmartSteps programme by the vascular surgeons in 
Beaumont Hospital and the Mater Misericordiae Hospital will be informed of the 
research study.  Participants must complete an induction day before commencing 
the SmartSteps programme.  Participants will be informed of the research study at 
the induction day.  A brief summary of the study will be provided to explain the 
study to the individuals and provide contact details.  Following an expression of 
interest, potential subjects will be asked to visit the Vascular Research Unit in the 
School of Health and Human Performance.  They will be told by agreeing to attend 
the first session they are not obligated to participate in the study.  An explanation 
will be given to each potential subject to explain the nature, benefits, risks and 
discomforts of the study.  They will be provided with a plain language statement, 
and the informed consent will be explained.  They will be encouraged to ask 
questions, and any individual with doubts about participating in the study will have 
an opportunity to ask questions.  Individuals who wish to participate in the study will 
have to provide written informed consent.  Contact details will be provided to 
ensure all queries or concerns of the participant can be dealt with immediately. 
2.6 PLEASE EXPLAIN WHEN, HOW, WHERE, AND TO WHOM RESULTS WILL BE 
DISSEMINATED, INCLUDING WHETHER PARTICIPANTS WILL BE PROVIDED WITH 
ANY INFORMATION AS TO THE FINDINGS OR OUTCOMES OF THE PROJECT? 
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The results will form the basis for a postgraduate masters and will be presented at 
scientific meetings and published in scientific journals.  The identity of individual 
participants will not be divulged.  Group information will only be presented.  
Participants will be provided with a copy of their results, summarising information 
such as body mass index, blood pressure and cholesterol levels. 
2.7 OTHER APPROVALS REQUIRED Has permission to gain access to another location, 
organisation etc. been obtained?  Copies of letters of approval to be provided when 
available. 
  
 YES  NO  NOT APPLICABLE 
 
 (If YES, please specify from whom and attach a copy.  If NO, please explain when this 
will be obtained.) 
      
 
2.8 HAS A SIMILAR PROPOSAL BEEN PREVIOUSLY APPROVED BY THE REC? 
 
 YES  NO 
DCUREC/2005/004:   Effect of acute exercise and muscle glycogen on postprandial 
lipemia 
DCUREC/2006/? OPEEC Study - Obesity, Prandrandial Lipemia, Endothelial function 
and Exercise in Children Study 
 
3. RISK AND RISK MANAGEMENT 
 
3.1 ARE THE RISKS TO SUBJECTS AND/OR RESEARCHERS ASSOCIATED WITH YOUR 
PROJECT GREATER THAN THOSE ENCOUNTERED IN EVERYDAY LIFE? 
 
 YES  NO If YES, this proposal will be subject to full REC review 
If NO, this proposal may be processed by expedited 
administrative review 
 
3.2 DOES THE RESEARCH INVOLVE: 
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 YES N
O 
 use of a questionnaire? (attach copy)?   
 interviews (attach interview questions)?   
 observation of participants without their knowledge?   
 participant observation (provide details in section 2)?   
 audio- or video-taping interviewees or events?   
 access to personal and/or confidential data (including student, 
patient or client data) without the participant’s specific consent? 
  
 administration of any stimuli, tasks, investigations or procedures 
which may be experienced by participants as physically or 
mentally painful, stressful or unpleasant during or after the 
research process? 
  
 performance of any acts which might diminish the self-esteem 
of participants or cause them to experience embarrassment, 
regret or depression? 
  
 investigation of participants involved in illegal activities?   
 procedures that involve deception of participants?   
 administration of any substance or agent?   
 use of non-treatment of placebo control conditions?   
 collection of body tissues or fluid samples?   
 collection and/or testing of DNA samples?   
 participation in a clinical trial?   
 administration of ionising radiation to participants?   
 
3.3 POTENTIAL RISKS TO PARTICIPANTS AND RISK MANAGEMENT PROCEDURES  
1. Exercise carries with it a very small risk of discomfort, abnormal heart 
rhythms, heart attack, or death in less than one in 30,000 patients.  Subjects 
will be continuously monitored using a 12 lead ECG. 
2. Drawing blood may cause a slight pain where the needle is inserted and can 
leave a bruise.  A person trained to take blood will be used to decrease these 
risks.  The amount of blood drawn is not harmful. 
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3. Assessment of BF, VR and PORH will require restriction of blood flow for up 
to 10 minutes.  This may cause slight discomfort in the leg, which will go away 
after the blood pressure cuff in deflated.  
Alternatives to the risks:  Analysis of circulating levels of blood lipids cannot be 
undertaken without a sample of blood.  The investigators are certified and 
experienced in phlebotomy and plethysmography.   
 
3.4 ARE THERE LIKELY TO BE ANY BENEFITS (DIRECT OR INDIRECT) TO PARTICIPANTS 
FROM THIS RESEARCH? 
 
 YES  NO Participants will be provided with a copy of their results, 
summarising information such as blood pressure and 
cholesterol levels       
 
3.5 ARE THERE ANY SPECIFIC RISKS TO RESEARCHERS? (e.g. risk of infection or where 
research is undertaken at an off-campus location) 
  
 YES  NO Working with blood and needles carries risks, however 
the exposure to blood and needles is minimal and the 
School of Health and Human Performance has standard 
operating procedures for the handling of biological 
products. 
 
 
3.6 ADVERSE/UNEXPECTED OUTCOMES (see Guidelines) 
The School of Health and Human Performance has the facilities to implement all 
aspects of this study and has an emergency plan for adverse events.  In the unlikely 
event of a major adverse outcome, an ambulance will be called and the participant 
will immediately be sent to Beaumont Hospital. In the unlikely event of a minor 
adverse outcome, the situation will be dealt with by the attending study physician 
with subsequent attention at the on-campus VHI SwiftCare clinic if required.   
3.7 MONITORING (see Guidelines) 
The principal investigator will be involved in all aspects of the research, including 
participant recruitment and data collection.  The research team will have weekly 
meetings to update on all aspects of the study.  The School of Health and Human 
Performance has a detailed list of Standard Operating Procedures for each of the 
protocols in this study.  All researchers, including students, must be familiar with the 
procedures and the Safety Statement before beginning data collection. 
3.8 SUPPORT FOR PARTICIPANTS  
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This project does not require additional support for participants 
 
 
 
 
3.9 DO YOU PROPOSE TO OFFER PAYMENTS OR INCENTIVES TO PARTICIPANTS? 
 
 YES  NO (If YES, please provide further details.)      
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4. INVESTIGATORS’ QUALIFICATIONS, EXPERIENCE AND SKILLS (Approx. 200 words – 
see Guidelines) 
 
      
Prof. Moyna is an exercise physiologist and has extensive experience in 
cardiovascular research. 
Dr. Noel McCaffrey is a physician with extensive experience in exercise related 
research 
Mr. Kevin O’Hara is a graduate student in the School of Health and Human 
Performance, DCU.  He has extensive experience in studies involving humans.   
Ms. Sarah Hughes is a graduate student in the School of Health and Human 
Performance, DCU.  She has extensive experience in studies involving human 
experimentation, and has undertaken extensive training in ultrasonography under 
the guidance of Cleona Gray, Chief Vascular Technologist in the Department of 
Vascular Surgery in the Mater Hospital, Dublin.  Sarah is also a certified 
phlebotomist. 
Dr Ronan Murphy has 12 years of post PhD experience and training in cell and 
molecular biology, vascular biology, and thrombosis & haemostasis. He received his 
undergraduate degree and Ph.D. with NUI Galway. Following this he worked for two 
years as a Clinical Research Scientist in the field of Pharmacogenomics. He was 
awarded a Fellowship from the HRB to work on bleeding disorders.  Thereafter, he 
went to work for Prof. S.J. Shattil, at The Scripps Research Institute, San Diego (2000-
2003). He has also been a visiting scientist to the Blood Research Institute, 
Milwaukee, USA. 
Dr. Catherine Woods is Head of the School of Health and Human Performance, 
Catherine and Dr. Noel McCaffrey established the community based Smart Steps 
rehabilitation program in DCU.  Dr Woods is actively involved in the co-ordination of 
the HeartSmart classes. 
Brona Furlong has recently graduated first in her class with a 1st class honours 
degree in Sports Science and Health.  She is currently enrolled as a PhD student in 
the School of Health and Human Performance.  She has extensive experience in 
blood sampling and research involving human subjects.  Brona will assist with data 
collection and supervising classes. 
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5. CONFIDENTIALITY/ANONYMITY 
 
5.1 WILL THE IDENTITY OF THE PARTICIPANTS BE PROTECTED? 
 
 YES  NO (If NO, please explain) 
 
 
 
IF YOU ANSWERED YES TO 5.1, PLEASE ANSWER THE FOLLOWING QUESTIONS: 
 
5.2 HOW WILL THE ANONYMITY OF THE PARTICIPANTS BE RESPECTED? (see Guidelines) 
Confidentiality is an important issue during data collection.  Participant’s identity 
and other personal information will not be revealed, published or used in further 
studies.  Subjects will be assigned an ID number under which all personal 
information will be stored in a secure locked cabinet and saved in a password-
protected file in a computer at DCU.  The principal investigator, and collaborators 
listed on this ethics application will have access to the data. 
5.3 LEGAL LIMITATIONS TO DATA CONFIDENTIALITY: (Have you included appropriate 
information in the plain language statement and consent form?  See Guidelines) 
 
 YES  NO (If NO, please advise how participants will be advised.) 
      
 
 
 
6 DATA/SAMPLE STORAGE, SECURITY AND DISPOSAL (see Guidelines) 
 
 
6.1 HOW WILL THE DATA/SAMPLES BE STORED? (The REC recommends that all data be 
stored on campus) 
 
Stored at DCU      
Stored at another site     (Please explain where and for 
what purpose) 
      
 
6.2 WHO WILL HAVE ACCESS TO DATA/SAMPLES? 
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Access by named researchers only         
Access by people other than named researcher(s)  (Please explain who and for 
what purpose)  
Other  :     (Please explain) 
       
 
6.3 IF DATA/SAMPLES ARE TO BE DISPOSED OF, PLEASE EXPLAIN HOW, WHEN AND BY 
WHOM THIS WILL BE DONE? 
The principal investigator will be responsible for security of the data.  The data will 
be kept in locked cabinet in the Cardiovascular Research Unit in the School of Health 
and Human Performance in DCU. Access to the data will only be attainable by the 
named researchers.  Data will be kept for a minimum of five years from the date of 
publication of the research.  Aside from the named researchers, no others will have 
access to the raw data.  Data will be shredded by Prof. Moyna after 5 years. 
 
  
Effect of Acute Exercise on Postprandial Lipemia and Endothelial Dysfunction in Men with Peripheral 
Arterial Disease 
__________________________________________________________________________________ 
97 
 
7. FUNDING 
 
 
7.1 HOW IS THIS WORK BEING FUNDED? 
 NA 
 
7.2 PROJECT GRANT NUMBER (If relevant and/or known) 
 NA 
 
7.3 DOES THE PROJECT REQUIRE APPROVAL BEFORE CONSIDERATION FOR FUNDING 
BY A GRANTING BODY?  
 
 YES  NO  
 
 
7.4 HOW WILL PARTICIPANTS BE INFORMED OF THE SOURCE OF THE FUNDING? 
 NA 
7.5 DO ANY OF THE RESEARCHERS, SUPERVISORS OR FUNDERS OF THIS PROJECT HAVE 
A PERSONAL, FINANCIAL OR COMMERCIAL INTEREST IN ITS OUTCOME THAT 
MIGHT COMPROMISE THE INDEPENDENCE AND INTEGRITY OF THE RESEARCH, OR 
BIAS THE CONDUCT OR RESULTS OF THE RESEARCH, OR UNDULY DELAY OR 
OTHERWISE AFFECT THEIR PUBLICATION? 
 
 YES  NO (If Yes, please specify how this conflict of interest will be 
addressed.) 
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APPENDIX: B 
8. PLAIN LANGUAGE STATEMENT (Approx. 400 words – see Guidelines) 
Plain Language Statement 
Dublin City University 
Project Title: Effect of Acute Exercise on Postprandial Lipemia in Peripheral Arterial 
Disease 
The Research Study will take place in the School of Health and Human 
Performance, DCU. 
The principle investigator is:  Prof. Niall M. Moyna, 
(Tel:  7008802, Fax: 7008888, Email: 
niall.moyna@dcu.ie) 
I. The way the body processes the fat we eat is one of the factors that 
influences our risk of developing heart disease.  After a single fatty meal, the 
level of fat in the bloodstream increases at first and then decreases again 
over an 8 hour period.  Individuals who are not capable of processing fatty 
meals efficiently have a high concentration of fat in their bloodstream over a 
prolonged period which may impair blood vessel function.  This study will 
investigate if a single bout of exercise prior to feeding can counteract the 
impairment in blood vessel function following a high fat meal in patients with 
PAD.  The study will require that you make 4 visits to the Vascular Research 
Unit in the School of Health and Human Performance in DCU. 
II. Visit 1:  During the first visit you will undergo a brief physical examination and 
have your weight, height and body fat measured using fat calipers.  You will 
then undertake a treadmill test.  This will involve you walking until the pain in 
your legs forces you to stop.  The electrical activity of you heart will be 
assessed by a 12 lead electrocardiogram.  This is a special machine that takes 
12 different views of your heart (like photographs) while you’re exercising. 
You will have electrodes placed on your chest to measure the electrical 
activity of my heart.  For this, and all subsequent exercise tests, you will be 
fitted with a mouthpiece connected to a machine to measure the 
composition of gases in your breath.  
Visit 2 and 3:  The second and third visit will take place within 12-14 h of each 
other.  You will visit the VRU between 6 and 7 pm and walk on a treadmill.  
You will walk until you get claudication pain and then you will rest until it 
goes away.  You will repeat this cycle of walking and recovery until you burn 
the 500 calories. 
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You will return to the VRU the next morning to undergo a 6 h oral fat 
tolerance test (visit 3).  Before the fat meal, you will have a small plastic tube, 
called a catheter, inserted into a vein in your arm to facilitate the taking of 
blood samples.  You will eat a fatty meal and then have a blood sample taken 
and 30 min, I hour, 2 hours, 4 hours and 6 hours following the meal.  The 
health of your arteries will be assessed at the same time that the blood 
samples are taken.  This will be done by using an ultrasound to take an image 
of your blood vessel.  This involves blocking the blood flow to your arm for 5 
minutes using a blood pressure cuff and taking one spray of glyceryl trinitrate 
under your tongue.  During this time you will be free to read and work 
quietly.  The total amount of blood taken during this visit will be 
approximately 7 tablespoons. 
On the evening prior the fourth visit you will rest quietly at home and visit 
the VRU the next morning to undergo a 6 h oral fat tolerance test.  The same 
measurements will be taken after the meal as in visit 3.   
You will consume your normal diet for 3 d before and will not undertake 
strenuous physical activity for 24 hours prior to each fat test.  You will fast for 
12 hours before each fat test.   For 2 days before the first fatty meal test, you 
will record the food you eat in a diary.  You will follow the same diet for the 2 
days before the second fatty meal test.  
 III.  1. Exercise carries with it a very small risk of discomfort, abnormal heart 
rhythms, heart attack, or death in less than 1 in 30,000 patients.  Your 
heart rate will be continuously monitored using a 12 lead ECG.     
2.  Drawing blood may cause a slight pain where the needle is inserted and 
may leave a bruise.  A person trained to take blood will be used to 
decrease these risks.  
3.  Taking an ultrasound image of your arm requires blocking the blood flow 
to your arm for 5 minutes using a blood pressure cuff.  This may cause 
slight discomfort in your arm, which will go away after the blood pressure 
cuff in deflated.  The glyceryl trinitrate used in this study may cause a 
headache that could last 5 to 10 min.  
IV. Your confidentiality will be guarded.  All information we gather will be stored 
in a secure filing cabinet.  The results of the study will be used for a 
postgraduate project and may be published in academic journals. You will 
not be identified, as your information will be presented as part of a group.  
You will be assigned an ID number under which all personal information will 
be stored in the secure locked filing cabinet and saved in a password 
protected file in a computer at DCU.  You need to be aware that 
confidentiality of information provided can only be protected within the 
limitations of the law.  It is possible for data to be subject to subpoena, 
freedom of information claim or mandated reporting by some professions.  
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VI. Involvement in this study is completely voluntary.  You may withdraw from 
the Research Study at any time.  Withdrawal from the study will not affect 
your participation in the SmartSteps Programme or the medical management 
of your condition. 
VIII. If you have concerns about this study and wish to contact an independent 
person, please contact: The Secretary, Dublin City University Research Ethics 
Committee, c/o Office of the Vice-President for Research, Dublin City 
University, Dublin 9.  Tel 01-7008000 
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APPENDIX: C 
 
9. INFORMED CONSENT FORM (Approx. 300 words – see Guidelines) 
 
Informed Consent 
Dublin City University 
Project Title Effect of Acute Exercise on Postprandial Lipemia in Peripheral Arterial 
Disease 
Principle Investigator Prof. Niall M. Moyna 
Introduction to this study 
The way the body processes the fat we eat is one of the factors that influences our 
risk of developing heart disease.  After a single fatty meal, the level of fat in the 
bloodstream increases at first and then decreases again over an 8 hour period.  
Individuals who are not capable of processing fatty meals efficiently have a high 
concentration of fat in their bloodstream over a prolonged period which may impair 
blood vessel function.  The purpose of this study is to investigate if a single bout of 
exercise prior to feeding can counteract the impairment in blood vessel function 
following a high fat meal in patients with PAD. 
Participants Requirements 
1. I will visit the Vascular Research Unit in the School of Health and Human 
Performance DCU on 4 separate days.   
2. During the first visit I will undergo a brief physical examination and I will also have 
my weight, height and body fat measured using fat calipers.  I will then walk on a 
treadmill.  The treadmill speed will stay at 2.0 miles per hour and the incline will 
increase by 2.0% every 2 minutes.  I will continue walking until the pain in my leg 
forces me to stop.  The electrical activity of my heart will be assessed by a 12 lead 
electrocardiogram.  This is a special machine that takes 12 different views of my 
heart (like photographs) while I am exercising.  I will have electrodes placed on my 
chest to measure the electrical activity of my heart.  For this, and all subsequent 
exercise tests, I will be fitted with a mouthpiece connected to a machine to 
measure the composition of gases in my breath  
3. The main part of the study will involve the collection of blood samples following 
consumption of two high fat meals.  Before each fat meal, I will have a small plastic 
tube, called a catheter, inserted into a vein in my arm to facilitate the taking of 
blood samples.  I will eat a fatty meal and then have a blood sample taken and 30 
min, I hour, 2 hours, 4 hours and 6 hours following the meal.  The health of my 
arteries will be assessed at the same time that the blood samples are taken.  During 
 
Effect of Acute Exercise on Postprandial Lipemia and Endothelial Dysfunction in Men with Peripheral 
Arterial Disease 
__________________________________________________________________________________ 
102 
 
this time I will be free to read and work quietly.  The total amount of blood taken 
during this visit will be approximately 100 ml or 7 tablespoons. 
4. On the evening before one of the fatty meals, I will go to DCU to walk until I burn 
between 500 calories.  I will walk until I get claudication pain and then I will rest 
until it goes away.  I will repeat this cycle of walking and recovery until I burn the 
500 calories.  On the evening before the other fatty meal test, I will rest quietly at 
home. 
5. For 2 days before each fatty meal test I will not be able to do any exercise or 
strenuous physical work (e.g. gardening).  I will also not be able to drink alcohol. 
6. For 2 days before the first fatty meal test, I will record the food I eat in a diary.  I will 
follow the same diet for the 2 days before the second fatty meal test. 
7. To test the health of the arteries in my arms I will lie on my back, and an ultrasound 
will be placed on my upper arm to create an image of my artery.  After the first 
image is recorded, a blood pressure cuff will be inflated on my forearm to block 
blood flow for five minutes.  This may be uncomfortable.  The cuff will be released 
and the images of my arteries repeated.  I will rest for 15 minutes and then have 
one spray of glyceryl trinitrte sprayed under my tongue.  The glyceryl trinitrate will 
cause my arm arteries to enlarge and how much they enlarge will again be 
documented by taking a third set of pictures.  If I am taking Viagra I will notify Kevin 
O’Hara.  I will not take  iagra for at least 24 hours before the two visits involving the 
high fat meal.   
 
Potential risks to participants from involvement in the Research Study  
1. Exercise testing carries with it a very small risk of abnormal heart rhythms, heart 
attack, or death in less than one in 30,000 patients.  Your heart will be continuously 
monitored using a 12 lead ECG and a physician will be present. 
2. Drawing blood may cause a slight pain where the needle is inserted and can leave a 
bruise.  A person trained to take blood will be used to decrease these risks. 
3. The amount of blood drawn is not harmful; however, if I have a history of anaemia, I 
should inform the investigator. 
4. To assess the resistance vessels in my calf it will require blocking the blood flow to 
my calf for 5 minutes.  This may cause slight discomfort in the leg, which will go away 
after the blood pressure cuff in deflated 
Benefits (direct or indirect) to participants from involvement in the Research Study 
After completing the study I will be provided with a copy of my results, summarising 
information such as my body mass index, blood pressure and cholesterol levels.  There 
are no other direct benefits to me. 
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Participant – please complete the following (circle Yes or No for each question) 
Have you read or had read to you the Plain Language Statement? Yes  No  
Do you understand the information provided?    Yes  No  
Have you had an opportunity to ask questions and discuss this study? Yes  No  
Have you received satisfactory answers to all your questions?  Yes  No  
Advice as to arrangements to be made to protect confidentiality of data, including that 
confidentiality of information provided is subject to legal limitations. 
Your identity and other personal information will not be revealed, published or used in 
further studies.  You will be assigned an ID number under which all personal information 
will be stored in a secure locked cabinet and saved in a password protected file in a 
computer at DCU.  The named investigators will have access to the data.  Data will be 
shredded after 5 years by Prof. Moyna. 
Confidentiality is insured, but you must be aware that confidentiality of information 
provided can only be protected within the limitations of the law.  It is possible for data 
to be subject to subpoena, freedom of information claim or mandated reporting by 
some professions. 
If you are in a dependent relationship with any of the researchers their involvement in 
the project will not affect ongoing assessment/grades/management or treatment of 
health at DCU.  Withdrawal from this study will not affect your participation in the 
HeartSmart programme or the medical treatment of your condition. 
Signature: 
I have read and understood the information in this form.  The researchers have answered 
my questions and concerns, and I have a copy of this consent form.  Therefore, I (print 
name) ______________________ consent to take part in this research project entitled 
Effect of Acute Exercise on Postprandial Lipemia in Peripheral Arterial Disease 
Participants Signature:  ____________________________________ 
Name in Block Capitals       
Witness:          
Date:          
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Appendix D 
Data Collection sheets 
Screening Visit 
Last Name: ________________    Date:  _________ 
 
First Name: _______________    Subject ID:  _________ 
 
Date of Birth:  ____/____/____    Age:        _       yrs  
Contact Details  
Contact number (home) ______________ Contact number (mobile) ________ 
Email Address  ______________ 
Informed consent signed    Yes  □   No  □    
   
Medications:  _________________________________________________________ 
                         _________________________________________________________  
                         _________________________________________________________ 
Anthropometrics 
Height: _________ cm    BMI/BSA ___________________ 
Weight: _________ kg    BP:  ______ mmHg 
 
Any comments: _________________________________________________________ 
                              _________________________________________________________ 
                              _________________________________________________________ 
                              _________________________________________________________ 
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General Health Questionnaire 
 
Name:……………………………….. Occupation:…………………………… 
 
Address:………………………………………………………………………………. 
 
Telephone: (Home)………………….. (Work):……………………………….. 
_____________________________________________________________________ 
 
Do you have, or have you ever suffered from: -Diabetes?   Yes / No 
 
         -Asthma?   Yes / No 
 
         -Epilepsy?   Yes / No 
 
Have you ever had pains in your chest or heart?    Yes / No 
 
Do you ever feel faint or have spells of dizziness?    Yes / No 
 
Do you have or have you ever had high blood pressure?   Yes / No 
 
Have you ever been told you have high cholesterol or been on medication for cholesterol? 
                                                                                                                        Yes / No 
Do you have a muscle, back or joint problem that could be aggravated by physical                                                                                                             
activity or made worse with exercise?     Yes / No 
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Do you have any current injuries?      Yes / No 
 
In the past week, have you suffered from any illness which required you to be in bed or off 
work for one day or more?                               Yes / No 
 
Do you smoke?   If yes, how many per day?   Yes / No 
 
Do you drink?               If yes, how many units per week?  Yes / No 
 
Is there a good physical reason not mentioned here why you should not carry out 
laboratory testing?        Yes / No 
Are you currently taking vitamin supplements? If so please state brand and dosage 
___________________________________________________________________ 
___________________________________________________________________ 
 
Please provide any further information concerning any condition/complaints which you 
suffer from and any medication which you may be taking by prescription or otherwise: 
…………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………… 
 
…………………………………………………………………………………………………………… 
Date:     Signature: 
Authorising Signature: 
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Oral Fat Tolerance Test  
 
Date: ______________                             Trial (Control/Exercise):_____________ 
Supervised by: _______________           Canula Insertion: __________________ 
 
Control of prior exercise, diet and alcohol 
Have you consumed any alcohol during the last 48 hours?                                           Yes / No 
Apart from the treadmill walk in the laboratory, have you undertaken any exercise or 
prolonged strenuous physical work over the last 48 hours?                                         Yes / No 
Have you closely followed the diet you recorded prior to your fatty meal test?      Yes / No 
 
Test Meal 
 
Body Surface Area (m2)               ________________   
Croissants (100g/2m2)                 ________________ 
Butter (35g/2m2)                          ________________ 
Chocolate (45g/2m2)                    ________________ 
Pringles (24g/2m2)                       ________________ 
Total fat content (g)                      ________________ 
Total carbohydrate content (g)     ________________ 
Test meal started                         ________________ 
Test meal finished                        ________________ 
Water consumed with meal (ml)   ________________ 
 
Meal finished completely    ____________ 
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Blood Sample                      Due time             Time taken if different              Vacutainers 
0Hr                                     __________         ___________________                   RR_P___ 
30min post meal              __________         ___________________                  RR_P___ 
1Hr post meal                    __________         ___________________                RR_P___ 
2Hr post meal                   ___________        ___________________                RR_P___ 
3Hr post meal                   ___________        ___________________                RR_P___ 
4Hr post meal                   ___________        ___________________                RR_P___ 
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Self Regulated Exercise 
Name: _______________________ 
Date:   _______________________ 
Bout Speed (km/hr) Grade(%) IC (mins) AC (mins) RPE RQ Rest 
EE 
(Kcal) 
1                 
2                 
3                 
4                 
5                 
6                 
7                 
 
Total Energy expended (Kcal) ___________ 
Total mins exercised __________________ 
Total Fat Oxidation (g) ____________________ 
Total Carbohydrate oxidation (g) _______________ 
Comments: 
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________
___________________________________________________________________________ 
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Appendix E 
Meal composition and nutritional information 
  
Energy Energy Protein CHO Fat 
Name (KJ/100g) (Kcal/100g) (g/100g) (g/100g) (g/100g) 
Cadburys Dairymilk Buttons 2205 525 7.5 56.8 30 
Mayfair Croissants 1647 393 8.6 48.4 18.3 
Kerrygold spreadable Butter 2982 725 0.7 0.6 80 
Original Pringles 2192 526 3.9 52 34 
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APPENDIX F 
 
Table 0.1:  Exercise Brachial artery diameter (cm) 
 Baseline 
(cm) 
Peak Dilation 
(cm) 
Absolute  
(cm) 
Percentage  
(cm) 
Baseline 0.43 ± 0.06 0.50 ± 0.07 0.07 ± 0.02 15.1 ± 4.3 
2 h post  0.46 ± 0.06 0.49 ± 0.06 0.04 ± 0.02 8.2 ± 5.7* 
4 h post 0.47 ± 0.08 0.52 ± 0.06 0.05 ± 0.03 12.4 ± 9.4 
Values are mean ± SD; *p<0.05 v Baseline  
 
 
Table 0.2:  Control Brachial artery diameter (cm) 
 Baseline 
(cm) 
Peak Dilation 
(cm) 
Absolute  
(cm) 
Percentage  
(cm) 
Baseline 0.42 ± 0.06 0.47 ± 0.06 0.05 ± 0.02 12.51 ± 2.94 
2 h post  0.45 ± 0.06 0.48 ± 0.07 0.03 ± 0.01 6.85 ± 1.85* 
4 h post 0.46 ± 0.08 0.50 ± 0.06 0.04 ± 0.02 10.43 ± 6.7 
Values are mean ± SD; *p<0.05 v Baseline  
 
 
Table 0.3:  Exercise Brachial artery diameter (cm) GTN 
 Baseline 
(cm) 
Peak Dilation 
(cm) 
Absolute  
(cm) 
Percentage  
(cm) 
Baseline 0.46 ± 0.04 0.52 ± 0.07 0.06 ± 0.04 12.27 ± 8.85 
2 h post  0.46 ± 0.07 0.54 ± 0.05 0.08 ± 0.02 17.36 ± 6.92 
4 h post 0.46 ± 0.07 0.53 ± 0.07 0.07 ± 0.03 16.32 ± 8.16 
Values are mean ± SD; 
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Table 0.4:  Control Brachial artery diameter (cm) GTN 
 Baseline 
(cm) 
Peak Dilation 
(cm) 
Absolute  
(cm) 
Percentage  
(cm) 
Baseline 0.46 ± 0.05 0.53 ± 0.06 0.07 ± 0.03 14.25 ± 6.10 
2 h post  0.46 ± 0.05 0.53 ± 0.04 0.07 ± 0.03 15.56 ± 6.84 
4 h post 0.47 ± 0.07 0.53 ± 0.07 0.07 ± 0.05 14.58 ± 11.36 
Values are mean ± SD; 
 
 
Table 0.5: Percentage changes in brachial artery Doppler flow - Exercise 
 Baseline 
(cm) 
Peak Dilation 
(cm) 
Absolute  
(cm) 
Percentage  
(cm/s) 
Baseline 60.79 ± 10.62 99.68 ± 27.02 38.89 ± 20.50 62.94 ± 16.63 
2 h post  59.24 ± 8.52 101.21 ± 13.56 41.97 ± 10.69 71.90 ± 19.72 
4 h post 54.10 ± 8.50 89.63 ± 19.94 35.54 ± 19.80 67.85 ± 36.43 
 
 
Table 0.6: Percentage changes in brachial artery Doppler flow - Control 
 Baseline 
(cm) 
Peak Dilation 
(cm) 
Absolute  
(cm) 
Percentage  
(cm) 
Baseline 56.53 ± 13.73 104.96 ± 18.83 48.43 ± 19.69 92.98 ± 52.60 
2 h post  54.61 ± 10.47 111.78 ± 13.73 57.16 ± 20.15 112.63 ± 56.56* 
4 h post 51.10 ± 10.40 87.61 ± 7.37 36.52 ± 12.46 77.57 ± 38.58 
Values are mean ± SD; *p<0.05 v Baseline  
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